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I. INTRODUCTION 
The ongoing debate in the United States about the legality 
and use of medical marijuana (also known as medicinal cannabis) 
is intriguing.1 There are those who would like to prevent, control, 
or even outright ban the use of medical marijuana. On the other 
hand, there are those who advocate for the legalization of medical 
marijuana in order to treat a variety of medical conditions, 
including debilitating diseases like AIDS, cancer, epilepsy, and 
chronic acute pain. Thrown into this debate is the conflicting 
treatment of marijuana by state and federal law. Marijuana is an 
illegal drug under federal law.2 The Controlled Substances Act 
(CSA), enacted in 1970, which outlawed marijuana and declared 
that it had no accepted medical use,3 also classifies marijuana as a 
Schedule I drug.4 Schedule I is the most dangerous category and 
 
 1.  The term “medical marijuana” is used in this article to refer to the whole 
unprocessed marijuana plant or to its crude extracts, which are not recognized or 
approved as medicine by the U.S. Food and Drug Administration (FDA). However, 
scientific study of the active chemicals in marijuana (cannabinoids) has led to the 
development of two FDA-approved medications (Marinol and Cesamet) in the 
race to develop new pharmaceuticals that will take advantage of the therapeutic 
benefits of cannabinoids, but will minimize or eliminate the harmful side effects 
from eating or smoking raw marijuana. See Drug Facts: Is Marijuana Medicine?, NIH 
NAT’L INST. ON DRUG ABUSE: THE SCIENCE OF DRUG ABUSE AND ADDICTION, 
http://www.drugabuse.gov/publications/drugfacts/marijuana-medicine (last 
updated July 2015). 
 2.  Controlled Substances Act (CSA), 21 U.S.C. §§ 801–971 (2000). 
 3.  Today, however, this proposition is becoming a less supported notion as 
states continue to adopt laws allowing for medical marijuana use. See Michael J. 
Aurit, Reefer Sadness: How Patients Will Suffer if Arizona Refuses to Implement Its Own 
Medical Marijuana Law, 5 PHOENIX L. REV. 543, 548–53 (2012). 
 4.  21 U.S.C. §§ 812(b)(1), (c)(c)(17) (2000).  
2
Mitchell Hamline Law Review, Vol. 42, Iss. 2 [2016], Art. 7
http://open.mitchellhamline.edu/mhlr/vol42/iss2/7
7. Shu-Acquaye (697-755) (Do Not Delete) 5/2/2016  9:53 PM 
2016] SHAPING LEGAL DEBATE ON MEDICAL MARIJUANA 699 
includes heroin, LSD, and ecstasy.5 This classification has been 
upheld even in the face of radical social changes in favor of 
legalization.6 Most recently, in the 2005 case of Gonzales v. Raich, 
the United States Supreme Court held that it is illegal to use, sell, 
or possess marijuana for medical use, even if the medical use is 
approved by the state and is in compliance with state law.7 
Although many states follow this Supreme Court ruling, a 
growing number have legalized the use and cultivation of 
marijuana for medicinal purposes.8 There are laws authorizing 
some legal form of medical marijuana in twenty-three states.9 Yet, 
state laws do not provide a carte blanche to citizens.10 States limit 
the circumstances and conditions under which medical marijuana 
may be cultivated, possessed, and used.11 Even with these 
limitations, these state laws invariably contradict federal law, given 
that the latter makes it a crime to cultivate, possess, or use 
marijuana for any purpose.12 
Courts and legal scholars are grappling with the question of 
whether the CSA preempts state marijuana laws, thereby rendering 
those state laws legalizing marijuana void.13 Some courts have held 
 
 5.  Aurit, supra note 3, at 550; Kevin A. Sabet, Much Ado About Nothing: Why 
Rescheduling Won’t Solve Advocates’ Medical Marijuana Problem, 58 WAYNE L. REV. 81, 
82–84 (2012).  
 6.  See infra Part VI (discussing the evolution of state and federal policies 
regarding marijuana legalization and the federal government’s steadfast position 
that marijuana is an illegal Schedule I drug). 
 7.  545 U.S. 1, 29 (2005). California passed the Compassionate Use Act in 
1996 which allowed for the use of medical marijuana. Id. at 5–6. The defendants 
were using marijuana properly under the Compassionate Use Act and one was 
growing marijuana plants at home for personal use, while the other relied on a 
third party for locally grown marijuana provided at no charge. Id. at 6–7. Federal 
DEA agents seized and destroyed their marijuana plants. Id. at 6–7. The 
defendants were compliant with state laws when arrested but guilty under federal 
DEA laws at the time. Id. at 7. The defendants sued the Attorney General, arguing 
that Congress had exceeded its Commerce Clause authority by legislating the 
behavior of a local citizen consuming a locally grown herb in his own home. Id. 
The Supreme Court held that the Commerce Clause authorized Congress to 
prohibit the local cultivation and use of marijuana in compliance with California 
law. Id. at 29. For further discussion of this case, see infra Section VII.A. 
 8.  See infra Table: Medical Marijuana Laws by State. 
 9.  See infra Table: Medical Marijuana Laws by State. 
 10.  See infra Table: Medical Marijuana Laws by State. 
 11.  See infra Table: Medical Marijuana Laws by State. 
 12.  See Aurit, supra note 3, at 553. 
 13.  Michael A. Cole, Jr., Note, Functional Preemption: An Explanation of How 
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medical marijuana statutes invalid under the theory that they are 
preempted by the CSA, while other courts have found that state 
laws are not preempted by the CSA14 and, as such, found some 
states medical marijuana laws to be enforceable.15 
Also, given the principle that federal law preempts state law, an 
important legal question now is the status of users of medical 
marijuana in states that do not conform to the federal law.16 The 
status of those medical marijuana users who are in compliance with 
state law in their use of marijuana, yet are in violation of federal 
law, is a tenuous one.17 Should the federal government enforce its 
own laws by investigating and prosecuting those who follow their 
state marijuana laws? Or should it exercise its investigatory and 
prosecutorial discretion and refrain from enforcing federal law? 
Another important issue is whether there is indeed momentum 
growing for deference towards state action, and if so, what should 
the role of the federal institutions, especially the Department of 
Justice (DOJ), be in shaping national policy? 
This article will also examine the social, economic, and legal 
pros and cons of legalization of medical marijuana to highlight the 
effects of medical marijuana legalization on the economy of a 
state.18 In sum, this paper looks at the current conundrum medical 
marijuana is in as it is stuck in the legal conflicts between state and 
federal laws in order to extrapolate some conclusions about the 
legal future of medical marijuana.19 
Particular cases are examined in order to demonstrate the 
influence of marijuana policies as a whole.20 In sum, this paper 
 
State Medicinal Marijuana Laws Can Coexist with the Controlled Substances Act, 16 
MICH. ST. U. J. MED. & L. 557, 558 (2012). 
 14.  See Emerald Steel Fabricators, Inc. v. Bureau of Labor & Indus., 230 P.3d 
518, 536 (Or. 2010). 
 15.  See Qualified Patients Ass’n. v. City of Anaheim, 115 Cal. Rptr. 3d 89, 105 
(Ct. App. 2010). See generally Cole, supra note 13, at 558; see infra Part VII. 
 16.  U.S. CONST. art. VI, cl. 2 (Supremacy Clause); Wyeth v. Levine, 555 U.S. 
555, 584 (2009) (Thomas, J., concurring) (“As long as it is acting within the 
powers granted it under the Constitution, Congress may impose its will on the 
States.”). 
 17.  See infra Part VI (discussing the mixed messages from the federal 
government regarding enforcement of federal marijuana laws); see infra text 
accompanying notes 261–76 (discussing the Ogden Memorandum).  
 18.  See infra Section V.B (discussing the high social costs of prohibition).  
 19.  See infra Part VI (discussing state and federal perspectives).  
 20.  See infra Part VII (laying out influential case law).  
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evaluates how much truth there is to the argument that there will 
soon be an end to federal marijuana prohibition.21 Although 
recreational use of marijuana has been recently legalized in Alaska, 
Colorado, Oregon, Washington, and Washington D.C., the focus of 
this paper is on the legalization of medical marijuana.22 Part II 
traces the origins of medical marijuana.23 Part III examines U.S. 
federal law’s relationship with international laws regulating 
marijuana to determine whether the United States may be violating 
international law if it allows states to legalize marijuana.24 The chart 
in Part IV provides an overview of state medical marijuana laws, 
showing, among other things, what amounts are legally permitted 
to be carried and the conditions for possession.25 Part V looks at the 
rationale the states provide for adopting or prohibiting marijuana 
laws.26 Parts VI and VII note the state and federal perspectives as 
well as the case law shaping the debate.27 Finally, Part VIII looks at 
the California Compassionate Use Act to see if it is a standard that 
is viable and could be emulated in other states.28 
II. TRACING THE ORIGINS OF MEDICAL MARIJUANA 
A  The Historical Use and Origins of Medical Marijuana around the 
World 
The use of medical marijuana has deep roots.29 One can trace 
its inception back across the millennia to the first written recording 
 
 21. Adam O’Neal, 2014: A Banner Year for Legalization of Pot, REAL CLEAR 
POLITICS (Jan. 15, 2014), http://www.realclearpolitics.com/articles/2014/01/15 
/2014_a_banner_year_for_legalization_of_pot__121231.html. 
 22.  See infra Part IV (containing chart summarizing medical marijuana laws 
in the states). Federal law does not distinguish between medicinal and recreational 
uses of marijuana. Both are forbidden under the CSA. 21 U.S.C. §§ 801–971 
(2000). 
 23.  See infra Part II (providing the history of medical marijuana). 
 24.  See infra Part III (discussing the role of international treaties in the 
debate over medical marijuana legalization). 
 25.  See infra Part IV (containing chart summarizing the status of medical 
marijuana in the states).  
 26.  See infra Part V (examining the pros and cons of prohibition).  
 27.  See infra Parts VI–VII. 
 28.  See infra Part VIII. 
 29.  See ALISON MACK & JANET JOY, MARIJUANA AS MEDICINE: THE SCIENCE 
BEYOND THE CONTROVERSY 14 (2000). 
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of marijuana’s use in Asia.30 That is, “the earliest known 
descriptions of marijuana appear in the ancient writings and 
folklore of India and China . . . .”31 Around 2700 BC, “[a]ccording 
to Chinese legend, Emperor Shen Nung,” the Father of Chinese 
medicine, “discovered marijuana’s healing properties as well as 
those of two other mainstays of Chinese herbal medicine, ginseng 
and ephedra.”32 Marijuana was listed in Emperor Shen’s book of 
drugs as a treatment for gout, malaria, and gas pain.33 In 1213 BC, 
Egyptians began using marijuana to treat glaucoma and 
inflammation, and to administer enemas.34 Across the Arabian Sea, 
bhang, a drink of cannabis and milk, was consumed in India as an 
anesthetic.35 
In 700 BC, the medical use of marijuana in the Middle East 
was recorded by the founder of Zoroastrianism, Zoroaster (or 
Zarathustra), in the Vendidad, one of the volumes of the Zend-
Avesta, the ancient Persian religious text.36 The Vendidad borrowed 
many cultural influences from the Vedas, mentioning bhang and 
listing marijuana as the most important of 10,000 medicinal 
plants.37 An earlier, and very central, Indian medical text, the 
Ayurvedic, recommended marijuana as a treatment for leprosy.38 A 
little further west, in ancient Greece, “[marijuana] was used to treat 
earache, edema, and inflammation.”39 
 
 30.  Id. 
 31.  Id. at 14. 
 32.  Id.; Classics of Traditional Chinese Medicine from the History of Medicine 
Division National Library of Medicine, U.S. NAT’L LIBR. OF MED., https://www.nlm.nih 
.gov/exhibition/chinesemedicine/emperors.html (last updated Apr. 16, 2012) 
(providing authority for assertion that Shen was the Father of Chinese medicine); 
see also ROBERT DEITCH, HEMP—AMERICAN HISTORY REVISITED: THE PLANT WITH A 
DIVIDED HISTORY 9 (2003) (“[Even] [t]he Chinese Emperor Fu Hsi (ca. 2900 BC), 
whom the Chinese credit with bringing civilization to China, seems to have made 
reference to Ma, the Chinese word for Cannabis, noting that Cannabis was a very 
popular medicine that possessed both yin and yang.”). 
 33.  See MACK & JOY, supra note 29, at 14; see also Historical Timeline: History of 
Marijuana as Medicine—2900 BC to Present, PROCON.ORG [hereinafter Historical 
Timeline], http://medicalmarijuana.procon.org/view.timeline.php?timelineID 
=000026 (last updated Aug. 13, 2013).  
 34.  Historical Timeline, supra note 33. 
 35.  Id. 
 36.  Id. 
 37.  Id. 
 38.  Id. 
 39.  Id.  
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Marijuana made its way to the New World when the settlers of 
Jamestown brought it with them across the Atlantic.40 Between 1745 
and 1775, George Washington, America’s first president, made 
regular recordings in his personal diary concerning his annual 
hemp production.41 Similarly, as noted in his farming diaries, 
Thomas Jefferson grew hemp at Monticello between 1774 and 
1824.42 Although, contrary to modern folklore, there is no evidence 
to suggest that Jefferson was a habitual smoker of hemp, tobacco, 
or any other substance.43 
Around the turn of the nineteenth century, Napoleon’s forces 
brought marijuana from Egypt to France.44 At the time Napoleon 
invaded Egypt, an expedition team of scientists accompanied his 
armed forces.45 This team brought marijuana back to France in 
1799.46 Once back in Europe, marijuana was tested for its sedative 
and pain-relieving effects and became widely accepted in Western 
medicine.47 French psychiatrist Jacques-Joseph Moreau found in 
studies in the 1840s that marijuana alleviated headaches and pains, 
boosted appetites, and was also helpful to people in sleeping.48 
Medical marijuana was reintroduced to the United Kingdom 
by William O’Shaughnessy, an army surgeon who introduced other 
doctors to the healing properties of marijuana.49 Marijuana was 
 
 40.  Id.; see also BERNARD SEGAL, PERSPECTIVES ON DRUG USE IN THE UNITED 
STATES 14 (1986) (“The Jamestown settlers brought the marijuana plant, 
commonly known as hemp, to North America in 1611 . . . . [H]emp fiber was an 
important export . . . . Indeed, in 1762, ‘Virginia awarded bounties for hemp 
culture and manufacture, and imposed penalties on those who did not produce 
it.’”). 
 41.  George Washington Grew Hemp, GEORGE WASHINGTON’S MOUNT VERNON 
(2015), http://www.mountvernon.org/george-washington/the-man-the-myth 
/george-washington-grew-hemp. 
 42.  See Historical Timeline, supra note 33.  
 43.  THOMAS JEFFERSON, THOMAS JEFFERSON’S FARM BOOK 348 (1824); see also 
Thomas Jefferson Papers, MASS. HISTORICAL SOC’Y (2003), http://www.masshist.org 
/thomasjeffersonpapers/. 
 44.  Historical Timeline, supra note 33. 
 45.  Id. 
 46.  Id. 
 47.  Id. 
 48.  Id. 
 49.  Ninth Report: Cannabis, HOUSE OF LORDS SELECT COMMITTEE ON SCIENCE 
AND TECHNOLOGY (1998), http://www.parliament.the-stationery-office.co.uk/pa 
/ld199798/ldselect/ldsctech/151/15103.htm; SCIENCE AND TECHNOLOGY 
COMMITTEE, CANNABIS: THE SCIENTIFIC AND MEDICAL EVIDENCE, 1997–98, Parl Deb 
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then used in the treatment of many conditions, including muscle 
spasms, headaches, cramps, asthma, diabetes, and acute and 
chronic pain.50 
B. Historical Background of the Use and Origins of Medical Marijuana 
in the United States 
Having made its way to Jamestown early in the history of 
European colonization, by 1850, marijuana had made its way into 
the United States Pharmacopeia—the official authority for 
prescription and over-the-counter medicines in early America.51 
Marijuana was listed as a treatment for a plentitude of afflictions, 
including neuralgia, tetanus, typhus, cholera, rabies, dysentery, 
alcoholism, opiate addiction, anthrax, leprosy, incontinence, gout, 
convulsive disorders, tonsillitis, insanity, and even excessive 
menstrual and uterine bleeding.52 
In 1906, President Roosevelt signed the Food and Drugs Act, 
known then simply as the Wiley Act.53 The Wiley Act regulated 
product labeling—a change from the then pre-market approach 
approved by the Federal Drug Agency (FDA).54 The legislation 
declared that a drug is misbranded “if the package fails to bear a 
statement on the label of, among other things, the quantity or 
proportion of any alcohol, morphine, opium, cocaine, 
heroin . . . or any [of their] derivative[s].”55 Ironically, labeling was 
not an issue when dealing with exports to a foreign country, given 
that the Act did not specifically apply to products “intended for 
 
HL (5th ser.) ¶ 2.5 [hereinafter SCIENCE AND TECHNOLOGY COMMITTEE]. 
 50.  MACK & JOY, supra note 29, at 15–16. 
 51.  Id. at 16. 
 52.  Id.; see SCIENCE AND TECHNOLOGY COMMITTEE, supra note 49. 
 53.  Wiley Act, Pub. L. No. 59–384, ch. 3915, § 1, 34 Stat. 768 (1906). 
 54.  Id. (“That it shall be unlawful for any person to manufacture within any 
Territory or the District of Columbia any article of food or drug which is 
adulterated or misbranded, within the meaning of this Act; and any person who 
shall violate any of the provisions of this section shall be guilty of a misdemeanor, 
and for each offense shall, upon conviction thereof, be fined not to exceed five 
hundred dollars, or shall be sentenced to one year’s imprisonment, for each 
subsequent offense and conviction thereof shall be fined not less than one 
thousand dollars or sentenced to one year’s imprisonment, or both such fine and 
imprisonment, in the discretion of the court.”); FDA History—
Part I, U.S. FOOD AND DRUG ADMIN., http://www.fda.gov/AboutFDA/WhatWeDo 
/History/Origin/ucm054819.htm (last updated June 6, 2009).  
 55.  Wiley Act § 8. 
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export to any foreign country and prepared or packed according to 
the specifications or directions of the foreign purchaser . . . .”56 
Since labeling was only an issue for products to be used 
domestically, the mislabeling of marijuana was irrelevant because 
the plant was not intended for the United States. 
The year 1910 ushered in strong feelings against the 
acceptance of marijuana in America.57 As a result, states passed laws 
prohibiting marijuana use. The first state to do so was Utah, which 
was quickly followed by nine others.58 Cannabis was also banned 
throughout the states during the 1910s, as part of a populist 
afterthought.59 These states did not pass these laws due to 
widespread public concern about marijuana. Rather, it was for 
implementing regulatory initiatives to discourage future use.60 In 
order to regulate the domestic manufacturing of opium as well as 
international trade, Representative Francis B. Harrison (D-NY) 
introduced three bills, one of which became the Harrison Act.61 In 
1915, President Wilson signed the Harrison Act, which became a 
model for much of the future drug regulations.62 The Harrison Act 
created a system of serial numbers on medications and also 
required physicians to register with the federal government if they 
 
 56.  Id. 
 57.  Dale H. Gieringer, The Origins of Cannabis Prohibition in California, CAL. 
NORML 1, 25 (Jun. 2006), http://www.canorml.org/background 
/caloriginsmjproh.pdf. 
 58.  Pete Guither, Why is Marijuana Illegal?, DRUGWARRANT.COM, 
http://www.drugwarrant.com/articles/why-is-marijuana-illegal (“[I]ncluding 
Wyoming (1915), Texas (1919), Iowa (1923), Nevada (1923), Oregon (1923), 
Washington (1923), Arkansas (1923), and Nebraska (1927).”). The state of New 
York outlawed cannabis in 1927. Gieringer, supra note 57, at 27, 35 (listing 
Massachusetts, Maine, Wyoming, Indiana, Utah, and Vermont). 
 59.  Gieringer, supra note 57, at 25. 
 60.  See id. 
 61.  Historical Timeline, supra note 33 (“Harrison also proposed that the 
government ‘impose a special tax upon all persons who . . . sell, distribute or give 
away opium or coca leaves . . . .’”); see Dennis Joseph Pfennig, Early Twentieth 
Century Responses to the Drug Problem, 6 OAH MAG. HIST. 2, 26 (1991). 
 62.  Pfennig, supra note 61, at 26; see also Historical Timeline, supra note 33; 
Presidential Timeline of Federal Drug Legislation in the United States, http://www 
.udel.edu/soc/tammya/pdf/crju369_presidentTimeline.pdf (last visited Mar. 13, 
2016). 
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wished to prescribe opiates.63 The Act became the basis for the 
Marijuana Tax Act of 1937.64 
By the 1930s, American pharmaceutical firms began selling 
extracts of marijuana as medicines.65 As demand for marijuana-
based medications increased, pharmaceutical firms attempted to 
produce consistently potent and reliable drugs from marijuana.66 
Congress consolidated the drug control effort in the Federal 
Bureau of Narcotics under the leadership of its commissioner, 
Harry Jacob Anslinger.67 Anslinger became the national voice of 
prohibition.68 His case for prohibition rested on the assertion “that 
the drug caused insanity [and] that it pushed people toward 
horrendous acts of criminality.”69 As the force of prohibition gained 
momentum, states begin to enact laws to regulate marijuana at the 
same time that new drugs such as aspirin, morphine, and other 
opium-derived medications began to show their effectiveness as 
painkillers.70 Consequently, forty-eight states had passed laws 
regulating marijuana by the end of 1936.71 
1. The Marijuana Tax Act of 1937 
The Marijuana Tax Act of 1937 was precipitated by publicized 
accounts of marijuana causing madness, inciting users to commit 
heinous, immoral crimes, as well as the perception that local and 
 
 63.  See Historical Timeline, supra note 33.  
 64.  Id. 
 65.  MACK & JOY, supra note 29, at 17 (“By the 1930s at least two American 
companies—Parke-Davis and Eli Lily—were selling standardized extracts of 
marijuana for use as an analgesic, an antispasmodic and sedative. Another 
manufacturer, Grimault & Company, marketed marijuana cigarettes as a remedy 
for asthma.”). 
 66.  Id. 
 67.  Brent Staples, The Federal Marijuana Ban Is Rooted in Myth and Xenophobia, 
N.Y. TIMES (July 29, 2014), http://www.nytimes.com/2014/07/30/opinion/high   
-time-federal-marijuana-ban-is-rooted-in-myth.html. 
 68.  Id. 
 69.  Id. Harry J. Anslinger was appointed Commissioner of the Federal 
Bureau of Narcotics. See id. “During 1936 the Bureau headlined the marihuana 
danger in its report [‘Traffic in Opium and Other Dangerous Drugs’]. For the first 
time it urged federal controls and presented a description of the vice, describing 
dire mental and moral changes among users.” Michael Schaller, The Federal 
Prohibition of Marihuana, 4 J. SOC. HIST. 61, 66 (1970). 
 70.  Staples, supra note 67. 
 71.  MARK EDDY, MEDICAL MARIJUANA: REVIEW AND ANALYSIS OF FEDERAL AND 
STATE POLICIES 2 (2010), https://www.fas.org/sgp/crs/misc/RL33211.pdf. 
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state efforts were failing to resolve the issue of illegal drug use.72 
Under the Marijuana Tax Act, growers, buyers, and sellers of 
marijuana were not only required to report and register marijuana 
sales, but were also expected to pay taxes.73 The unintended 
consequence of this imposed taxation was that it tended to prohibit 
marijuana, given that the added taxes would further remove 
incentives to potential buyers.74 The Act was the “federal 
government’s first attempt to regulate marijuana.”75 The 1914 
Harrison Act “maintained the right to use marijuana for medical 
purposes;” however, physicians and pharmacists were required to 
register with federal authorities and pay an annual tax or license 
fee for prescription or dispensation of marijuana.76 Consequently, 
this increased regulation resulted in a sharp drop in the demand 
for and use of marijuana.77 In 1942, marijuana lost its official 
recognition by the government as a legitimate medicine and was 
removed from the U.S. Pharmacopeia.78 
“Congress established mandatory minimum prison sentences” 
for federal drug offenses in 1951 with the passing of the Boggs Act 
by Representative Hale Boggs (D-La).79 Under the Boggs Act, first-
time offenses were given two to five year minimum sentences, 
including the offense of possession of marijuana.80 As a result, the 
sentencing recommendations failed to distinguish between 
personal drug use and drug trafficking.81 Congress included 
marijuana in the Narcotics Control Act of 1956, which resulted in 
stricter mandatory sentences for marijuana-related offenses which 
included raising the bar to make “[a] first-offense marijuana 
 
 72.  Id. 
 73.  Id. 
 74.  Id. 
 75.  Id. 
 76.  Rosalie Liccardo Pacula et al., State Medical Marijuana Laws: Understanding 
the Laws and Their Limitations 3–4 (ImpacTeen Research Paper Series                  
No. 13, 2001), http://www.oregon.gov/pharmacy/Imports/Marijuana/StaffInfo 
/StateMedicalMarijuanaLawsUnderstandingTheLawsAndTheirLimitations.pdf. 
 77.  Id. at 4. 
 78.  Id. 
 79.  Id.; Historical Timeline, supra note 33; MOLLY M. GILL, FAMILIES AGAINST 
MANDATORY MINIMUMS, CORRECTING COURSE: LESSONS FROM THE 1970 REPEAL OF 
MANDATORY MINIMUMS 2 (2008). 
 80.  Historical Timeline, supra note 33.  
 81.  Id. The motivation “behind the Boggs Act was the mistaken belief that 
drug addiction was a contagious and perhaps incurable disease and that addicts 
should be quarantined and forced to undergo treatment” for public safety. Id. 
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possession carr[y] a minimum sentence of 2–10 years with a fine of 
up to $20,000.”82 
2. The Controlled Substance Act (CSA) 
The 1970 CSA passed by Congress was a part of a 
comprehensive drug abuse prevention plan.83 This law was 
innovative in the United States, as it created and also incorporated 
a management system for narcotic and psychotropic drugs.84 The 
CSA was employed by Congress to control and regulate trade in, 
and the use of, such substances, as well as to satisfy the obligations 
of the United States under the Single Convention on Narcotic 
Drugs of 1961 and the subsequent Convention on Psychotropic 
Drugs of 1971.85 The CSA governs all aspects of the handling, 
production, sale, and use of various covered substances.86 The CSA 
created a five-tier system of schedules to classify substances.87 
Marijuana was placed in Schedule I, which are drugs “classified as 
having a high potential for abuse, no currently accepted medical 
use in treatment in the United States, and a lack of accepted safety 
for use of the drug or other substances under medical 
supervision.”88 
When considering the placement of marijuana in the five-tier 
system, Congress asked the Department of Health, Education, and 
Welfare for its recommendation.89 The response, by letter dated 
August 14, 1970, of Roger O. Egeberg, the Assistant Secretary for 
Health and Scientific Affairs, reads as follows: 
Some question has been raised whether the use of the 
plant itself produces ‘severe psychological or physical 
dependence’ as required by a schedule I or even schedule 
II criterion. Since there is still a considerable void in our 
knowledge of the plant and effects of the active drug 
 
 82.  Busted: America’s War on Marijuana, PBS: FRONTLINE, http://www.pbs.org 
/wgbh/pages/frontline/shows/dope/etc/cron.html (last visited Mar 13, 2016). 
 83.  Historical Timeline, supra note 33.  
 84.  Id. 
 85.  21 U.S.C. § 801(a); Sabet, supra note 5, at 84 (“As a signatory to these 
treatises, the U.S. is required by federal legislation to establish a range of 
requirements and prohibitions seeking to ensure that all psychoactive substances 
are used purely for legitimate medical and scientific purposes.”). 
 86.  Sabet, supra note 5, at 84.  
 87.  Id. at 85–87.  
 88.  Historical Timeline, supra note 33. 
 89.  Id. 
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contained in it, our recommendation is that marihuana 
be retained within schedule I at least until the completion 
of certain studies now underway to resolve the issue. If 
those studies make it appropriate for the Attorney 
General to change the placement of marijuana to a 
different schedule, he may do so in accordance with the 
authority provided under section 201 of the bill.90 
This shows that the quest for the reclassification of marijuana 
has been ongoing for over thirty years and the position still upheld 
by Congress today is probably buttressed by support from its 
historical stance of opposition to reclassification. 
In 1970, a presidential commission (later known as the Shafer 
Commission) was responsible for examining marijuana policy.91 In 
1971, the Shafer Commission recommended rescheduling 
marijuana.92 However, the president rejected their 
recommendation.93 In fact, prior to the Commission’s completion 
of its work, President Richard Nixon stated in a televised news 
conference on May 1, 1971: 
As you know, there is a Commission that is supposed to 
make recommendations to me about this subject. In this 
instance, however, I have such strong views that I will 
express them. I am against legalizing marijuana. Even if 
the Commission does recommend that it be legalized, I 
will not follow that recommendation . . . I can see no 
social or moral justification whatever for legalizing 
marijuana. I think it would be exactly the wrong step. It 
would simply encourage more and more of our young 
people to start down the long, dismal road that leads to 
hard drugs and eventually self-destruction.94 
As President Nixon had warned, he rejected the bipartisan 
Shafer Commission’s recommendation that the personal use of 
marijuana be decriminalized.95 
 
 90.  JON GETTMAN, THE 1995 MARIJUANA RESCHEDULING PETITION 224 (1995) 
(citing Letter from Roger O. Egeberg to Harley O. Staggers (Aug. 14, 1970)). 
These studies resulted in the 1972 Schafer Commission report, which 
recommended removing marijuana from the scheduling system and 
decriminalizing it. Id.  
 91.  Historical Timeline, supra note 33. 
 92.  Id. 
 93.  Id. 
 94.  Id. 
 95.  Id. However, over the course of the 1970s, eleven states decriminalized 
marijuana and most others reduced their penalties. See Busted, supra note 82.  
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3. Drug Enforcement Agency (DEA) 
Prior to the creation of the Drug Enforcement Agency (DEA), 
drug enforcement rested in the hands of two federal offices: the 
Bureau of Narcotics, located within the Treasury Department, and 
the Bureau of Drug Abuse Control.96 The Bureau of Narcotics was 
responsible for the control of marijuana and narcotics, such as 
heroin.97 By 1968, the recreational use of illegal drugs was 
becoming commonplace.98 In response to the steady rise in 
substance abuse, President Lyndon Johnson facilitated a 
restructuring of federal agencies that resulted in the Bureau of 
Narcotics and the Bureau of Drug Abuse Control merging under a 
single umbrella agency called the Bureau of Narcotics and 
Dangerous Drugs, located under the purview of the Department of 
Justice.99 Under the auspices of President Nixon, the Bureau of 
Narcotics and Dangerous Drugs and the Office of Drug Abuse Law 
Enforcement were merged to form the DEA as the single federal 
agency for drug control.100 President Nixon acted to end 
interagency rivalries, thereby maximizing the efficiency of the 
Justice Department and further focusing federal law enforcement 
operations on the drug trade.101 
4. The National Organization for the Reform of Marijuana Laws 
(NORML): Attempts to Reclassify Marijuana 
The National Organization for the Reform of Marijuana Laws 
(NORML), whose primary mission is to end marijuana prohibition, 
was founded in 1970 to give a voice to those Americans who 
opposed marijuana prohibition.102 In the decade after its founding, 
NORML led successful efforts to decriminalize minor marijuana 
offenses in eleven states and greatly reduce penalties in others.103 
On May 18, 1972, NORML filed an administrative petition with the 
 
 96.  U.S. Drug Enforcement Administration (DEA), ALLGOV, http://www.allgov 
.com/departments/department-of-justice/us-drug-enforcement-administration      
-dea?agencyid=7195 (last visited Mar. 13, 2016).  
 97.  Id. 
 98.  Id. 
 99.  Id. 
 100.  Id. 
 101.  Id. 
 102.  Introduction, NORML, http://norml.org/about/intro (last visited Mar. 
13, 2016). 
 103.  Id. 
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DEA asking the federal government to reclassify marijuana under 
the Controlled Substances Act as a Schedule V drug.104 However, 
the federal authorities at the DEA refused to accept the petition 
until obliged to do so by a U.S. Court of Appeals in 1974.105 
Eventually, in 1988, administrative law Judge Francis Young ruled 
that the therapeutic use of marijuana was recognized by a 
respected minority of the medical community and that marijuana 
met the standards of other legal medications.106 In any event, on 
December 30, 1989, DEA Administrator Jack Lawn overruled the 
decision of the administrative law judge, and reiterated that 
marijuana should remain a Schedule I controlled substance.107 In 
1994, a final decision in this over twenty-five year battle was 
rendered by the U.S. Court of Appeals, upholding that marijuana 
be maintained in Schedule I.108 Today, NORML continues to 
attempt to reform state and federal marijuana laws through voter 
initiatives and legislation.109 
 
 104.  Nat’l Org. for Reform of Marijuana Laws (NORML) v. Ingersoll, 497 F.2d 
654, 655–56 (D.C. Cir. 1974). 
 105.  Id. at 660 (holding that the rulemaking petition must be remanded to 
the Director of the DEA). 
 106.  Marijuana Rescheduling Petition, No. 86-22, 65 (U.S. Dep’t of Justice, 
Drug Enforcement Admin. Sept. 6, 1988), http://www.oregon.gov/pharmacy 
/Imports/Marijuana/Public/SRay/CourtDocket86-22.pdf (opinion and 
recommendation of administrative law judge). Young suggested that marijuana be 
rescheduled from Schedule I to Schedule II for nausea associated with cancer 
chemotherapy. Id. at 33. He also concluded that the evidence was insufficient to 
warrant the use of marijuana for glaucoma. Id. at 37. 
 107.  DRUG ENFORCEMENT ADMINISTRATION: A TRADITION OF EXCELLENCE: 1973–
2008, at 68 (2008). (“DEA Administrator Jack Lawn overruled the decision of one 
administrative law judge who had agreed with marijuana advocates that marijuana 
should be moved from Schedule I . . . . Lawn maintained that there was no 
medicinal benefit to smoking marijuana . . . . Lawn maintained that marijuana 
should remain a Schedule I controlled substance.”); Marijuana Scheduling, 54 
Fed. Reg. 53,767 (U.S. Dep’t of Justice, Drug Enforcement Admin. Dec. 29, 1989) 
(denial of petition). 
 108.  25 Years Ago: DEA’s Own Administrative Law Judge Ruled Cannabis Should Be 
Reclassified under Federal Law, NORML (Sept. 3, 2013), http://norml.org/news/2013 
/09/05/25-years-ago-dea-s-own-administrative-law-judge-ruled-cannabis-should-be-
reclassified-under-federal-law. 
 109.  Introduction, NORML, supra note 102. 
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5. National Institute on Drug Abuse (NIDA) 
The National Institute on Drug Abuse (NIDA) is the exclusive 
entity responsible for reporting data on marijuana in the United 
States.110 As a result, NIDA is authorized to issue contracts to grow 
marijuana for research.111 Because the United States is a signatory 
to the 1961 Single Convention treaty agreement which prohibits 
the production, trade, and possession of marijuana for non-medical 
purposes, and makes those activities punishable offenses under 
domestic law, the United States does run the risk of contravening 
the tenets of the Convention by legalizing marijuana.112 The Single 
Convention on Narcotics of 1961 mandated federal control of the 
production of any marijuana for scientific research, thereby 
rendering recreational marijuana a violation of the treaty and 
international law.113 Consequently, the treaty requires that 
governments (in this case, the federal government) create a single 
agency to monitor, regulate, and safeguard all of the national 
production of marijuana for research.114 NIDA became that 
agency.115 
Since 1968, the University of Mississippi has held a registration 
from NIDA and its predecessor agency to grow marijuana for 
government-approved research and has been the only legal source 
of marijuana in the United States for government-approved 
marijuana research under the direct guidance of the NIDA.116 
 
 110.  Nat’l Advisory Council on Drug Abuse, Provision of Marijuana and Other 
Compounds For Scientific Research—Recommendations of the National Institute on Drug 
Abuse National Advisory Council, NAT’L INST. ON DRUG ABUSE (1988), http: 
//archives.drugabuse.gov/about/organization/nacda/MarijuanaStatement.html 
[hereinafter Recommendations of NIDA] (last visited Mar. 13, 2016). 
 111.  Id. 
 112.  Single Convention on Narcotic Drugs of1961 art. 36, Mar. 30, 1961, 18 
U.S.T. 1407, 976 U.N.T.S. 105; see Matt J. Stannard, Case Note, Criminal LawA 
Canonical Conundrum Concerning Cannabis: How Wyoming’s Supreme Court Ignored Its 
Own Interpretative Rules and Read a Medical Marijuana Defense out of the Law, Burns v. 
State, 246 P.3d 283 (Wyo. 2011), 12 WYO. L. REV. 453, 457 (2012).  
 113.  See Single Convention on Narcotic Drugs of 1961, supra note 112, at art. 
2, ¶ 5. 
 114.  See Historical Timeline, supra note 33 (describing events of 1974). 
 115.  See NIDA’s Role in Providing Marijuana for Research, NAT’L INST. ON         
DRUG ABUSE, http://www.drugabuse.gov/drugs-abuse/marijuana/nidas-role-in      
-providing-marijuana-research (last visited Mar. 13, 2016). 
 116.  See Recommendations of NIDA, supra note 110.  
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III. THE UNITED STATES’ RELATIONSHIP WITH THE INTERNATIONAL 
LAWS REGULATING MARIJUANA 
In February of 1925, the League of Nations signed the 
International Opium Convention, a multilateral treaty restricting 
marijuana use to scientific and medical purposes for the first 
time.117 Egypt proposed that hashish (marijuana resin) be added to 
the list of compounds to be controlled by the convention.118 The 
convention authorized the production, use, or sale of cannabis only 
for state-approved scientific or medical purposes.119 Consequently, 
restrictions on importing and exporting cannabis resin were put 
into place.120 
While there were several international conventions addressing 
drugs,121 the most influential international treaty on U.S. federal 
policy was the Single Convention on Narcotic Drugs. Adopted in 
1961, the terms of the treaty provide a framework for modern U.S. 
policy and require participating countries to adopt measures to 
prevent the misuse and illicit trafficking of marijuana.122 Congress 
approved participation in the convention in 1967 and three years 
later passed the Comprehensive Drug Abuse Prevention and 
Control Act,123 “which provides the basis for current federal 
prohibitions regarding marijuana use.”124 The primary purpose of 
the treaty was to regulate selected drugs for use exclusively for 
 
 117.  See UNITED NATIONS OFFICE ON DRUGS AND CRIME, THE CANNABIS PROBLEM: 
A NOTE ON THE PROBLEM AND THE HISTORY OF INTERNATIONAL ACTION (Jan. 1, 
1962), https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin 
_1962-01-01_4_page005.html. 
 118.  Id. 
 119.  See MARTIN JELSMA, GLOBAL COMM’N ON DRUG POLICIES, THE 
DEVELOPMENT OF INTERNATIONAL DRUG CONTROL: LESSONS LEARNED AND STRATEGIC 
CHALLENGES FOR THE FUTURE 2–3 (Jan. 2011), http://www 
.globalcommissionondrugs.org/wp-content/themes/gcdp_v1/pdf/Global_Com 
_Martin_Jelsma.pdf./Global_Com_Martin_Jelsma.pdf. 
 120.  Id. 
 121.  See UNITED NATIONS OFFICE ON DRUGS AND CRIME, 2008 WORLD DRUG 
REPORT 21 (2008), https://www.unodc.org/documents/wdr/WDR_2008/WDR 
_2008_eng_web.pdf. 
 122.  See NAT’L RESEARCH COUNCIL, COMM. ON SUBSTANCE ABUSE AND HABITUAL 
BEHAVIOR, AN ANALYSIS OF MARIJUANA POLICY 2 (1982); Allison E. Don, Lighten Up: 
Amending the Single Convention on Narcotic Drugs, 23 MINN. J. INT’L L. 213, 224–25 
(2014). 
 123.  Pub. L. No. 91-513, 84 Stat. 1236 (1970). 
 124.  See NAT’L RESEARCH COUNCIL, supra note 122, at 2. 
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medical and scientific purposes.125 Under the Convention, drugs 
are divided into four Schedules, with cannabis in both Schedules I 
and IV.126 Schedules I and IV of the Convention encompass the 
most dangerous drugs, and this buttresses the fact that marijuana is 
considered “particularly liable to abuse and to produce ill effects 
[which] is not offset by any substantial therapeutic advantages.”127 
The Convention also provides guidelines for punishment, 
suggesting that signatory countries implement corresponding 
punishment and recommending imprisonment for serious 
violations.128 The compliance of member states under the 
Convention is monitored by the International Narcotics Control 
Board (the Board)129 and the Commission on Narcotic Drugs of the 
Economic and Social Council (the Commission)130 as created 
respectively.131 
Not surprisingly, the Board, as a party to the Convention, was 
especially interested in the United States, and in the progression 
towards the legalization of marijuana at the state level, particularly 
in Washington and Colorado.132 Consequently, in 2013, the 
President of the Board reiterated that “the 1961 Convention limits 
the licit use of narcotic drugs—including [marijuana]—to medical 
and scientific purposes.”133 He also stated, “[T]he 1961 
Convention . . . needs to be implemented worldwide, on the 
national but also on the sub-national level.”134 The Board requested 
that the U.S. government, “take effective measures to ensure the 
implementation of all control measures for cannabis plants and 
 
 125.  See Don, supra note 122, at 224 (citing Single Convention on Narcotic 
Drugs of 1961, supra note 112, at pmbl). 
 126.  Id. 
 127.  Id. 
 128.  Single Convention on Narcotic Drugs of 1961, supra note 112, at art. 
36(1)(a). 
 129.  See Don, supra note 122, at 225 (“The Single Convention provides the 
Board with specific powers in order to secure compliance should the Single 
Convention’s goals become threatened.”). 
 130.  Id. (“The Commission is entrusted with maintaining the Single 
Convention, including amending the Schedules and providing recommendations 
for scientific research.”). 
 131.  Id. 
 132.  Don, supra note 122, at 226. These states approved the use of marijuana 
for recreational purposes despite conflicting federal law. Id. at 214. 
 133. Id. (quoting RAYMOND YANS, REP. OF THE INT’L NARCOTICS CONTROL BOARD 
7 (2013)). 
 134.  Id.  
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cannabis, as required under the 1961 Convention, in all states and 
territories falling within its legislative authority.”135 Consequently, 
by publishing the Deputy Attorney General’s memo—reassuring 
the states that as long as they enacted a strong regulatory system to 
oversee the distribution of marijuana, the federal government will 
not become involved—the United States was publicly undermining 
the Board’s authority by ignoring the guidance that had been 
issued a few months prior.136 The force of the Single Convention 
treaty is unquestionably impacting marijuana legalization in the 
United States,137 although the states may be doing so without taking 
the Convention into consideration. The United States’ tolerance of 
states legalizing marijuana production and use is illustrative of the 
hypocrisy in its international treaty obligations.138 In the same vein, 
it is in conflict with the United States’ current practice of 
withholding aid from Mexico and Colombia as a punitive measure 
in response to their ineffective efforts against drug trafficking.139 
In the international arena, the United States is not the only 
country leading marijuana legalization. Uruguay passed a 
marijuana legalization bill—signed into law on December 23, 
2013—making it “the first in the world to legalize, regulate and tax 
the drug.”140 In a similar vein, in the mid-1970s, the Netherlands, 
hoping to decrease the use of heroin, decriminalized the use of 
marijuana.141 The Netherlands is a member of the Single 
Convention, and, despite its recognition that marijuana is an 
“illegal substance,” it does not prosecute users of the drug.142 
Additionally, the country allows for the presence of “coffee shops,” 
 
 135.  Id. at 226–27 (citation omitted). 
 136.  Id. at 227; see Memorandum from David Ogden, Deputy Att’y Gen., U.S. 
Dept. of Justice, to Selected U.S. Attorneys (Oct. 19, 2009) [hereinafter Ogden 
Memo], http://www.justice.gov/opa/documents/medical-marijuana.pdf. 
 137.  See Melanie Reid, The Quagmire that Nobody in the Federal Government Wants 
to Talk About: Marijuana, 44 N.M. L. REV. 169, 186–87 (2014). 
 138.  Id. at 187; see Press Release, U.N. Info. Serv., INCB President Calls on the 
U.S. Gov’t to Address Initiatives Aimed at Permitting Recreational Drug Use, U.N. 
Press Release UNIS/NAR/1164 (Mar. 14, 2013). 
 139.  Reid, supra note 137, at 186 (citation omitted). 
 140.  See Steven Nelson, Uruguay’s President Quietly Signs Marijuana Legalization 
Bill, U.S. NEWS & WORLD REP. (Dec. 26, 2013, 2:41 PM), http://www.usnews.com 
/news/articles/2013/12/26/uruguays-president-quietly-signs-marijuana                  
-legalization-bill. 
 141.  Don, supra note 122, at 229. 
 142.  Id. (citation omitted). 
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in which marijuana is sold.143 If these shops follow the established 
rules related to marijuana, law enforcement allow them to 
operate.144 
The international community is showing a gradual shift 
towards support for recreational marijuana, but the issue is whether 
this rises to the level that would warrant an amendment to the 
Single Convention to allow member states to legislate on 
recreational marijuana without constraints from international 
obligations.145 
IV. AN OVERVIEW OF STATE MEDICAL MARIJUANA LAWS 
The table below provides a simplistic overview of the states that 
have laws allowing and regulating medical marijuana use, and is 
current as of June 8, 2015.146 This table includes those jurisdictions 
permitting only limited access programs.147 This table also includes 
statutory references for those provisions, which allow medical 
marijuana in those “[thirty-eight] states and the District of 
Columbia that have passed or enacted some form of medical 
 
 143.  Id. at 230.  
 144.  Id. By purchasing their marijuana from “coffee shops,” users can get the 
drug safely, instead of having to risk receiving dangerous drugs from dealers on 
the street. Id. 
 145.  Id. at 243. 
 146.  Jalayne J. Arias et al., Medical Marijuana Summary of Programs and Limited 
Access Laws, THE NETWORK FOR PUB. HEALTH L. (June 8, 2015), 
https://www.networkforphl.org/_asset/sbth8b/State-Medical-Marijuana-Law         
-Table.pdf. The states marked with an asterisk indicate states that have “only 
Limited Access Marijuana Product Laws.” Id. The table shown is a condensed 
version of that created by The Network for Public Health, a collaboration between 
the Robert Wood Johnson Foundation and the Public Health Law Center at 
Mitchell Hamline School of Law. Id. The headings of the table are as follows: A 
“[s]pecifies the entity responsible for administration of the specific state’s medical 
marijuana program;” B “[lists] legal provisions authorizing the use of marijuana 
for medical purposes in the jurisdiction”; C specifies “provisions in 15 states 
permitting medical use of Cannabis products with low to zero THC and high CBD 
concentrations”; D “indicates if the legal authority provides for the operation of 
dispensaries to distribute medical marijuana; 23 jurisdictions allow dispensaries at 
this time;” E lists “the 24 jurisdictions with broad programs for patients to obtain 
and use marijuana for medical purposes;”; and F “indicates if the legal authority 
provides for the operation of dispensaries to distribute medical marijuana; 23 
jurisdictions allow dispensaries at this time.” Id. 
 147.  Id. 
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marijuana legislation.”148 Colorado and Washington were the first 
states to legalize the recreational use of medical marijuana.149 
 
  
 
 148.  Id. 
 149.  See COLO. CONST. art. XVIII, § 16; WASH. REV. CODE ANN. § 69.50.325 
(West 2015).  
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As can be seen in the table, the emerging trend in many states 
allowing marijuana use is also allowing for the medium of 
dispensation; consequently, states are incorporating policies 
regulating dispensaries.150 For example, unlike California and 
Colorado, which formally had their dispensaries regulated by state 
laws, in Washington and Michigan, dispensaries are just only 
beginning to emerge along with the need for policies to regulate 
them.151 
Dispensaries are subject to a wide range of regulations, which 
vary across the many jurisdictions that have confronted this issue. 
Some states, like Oregon, have created restrictions against charging 
for labor beyond the materials and utilities used, and others, like 
New Mexico, require any grower operations to be conducted in the 
form of a non-profit and prohibit price discounts for purchasing 
large volumes.152 In some states, “[t]he compensation that 
dispensaries may receive for providing marijuana . . . [to] some the 
number of patients the dispensary may [entertain]” is regulated or 
restricted as well.153 For example, California requires patients to 
form cooperatives and limits the dispersion of marijuana by the 
cooperatives to members of the cooperatives.154 Some “local 
communities have imposed zoning and licensing requirements on 
marijuana dispensaries,” while others seek to ban them 
completely.155 
V. THE RATIONALE FOR MEDICAL MARIJUANA: ADOPTION OR 
PROHIBITION? 
The legalization debate rages on between those advocating for 
legalization of medical marijuana and those who are opposed to it. 
Only twenty-two percent of Americans thought marijuana should 
be legal in 1991.156 That figure rose to forty-three percent by 2008 
 
 150.  Rosalie Liccardo Pacula et al., Assessing the Effects of Medical Marijuana 
Laws on Marijuana and Alcohol Use: The Devil Is in the Details 6–7 (Nat’l Bureau of 
Econ. Research, Working Paper 19302, 2013). 
 151.  Id.  
 152.  OR. REV. STAT. ANN. § 475.420(8) (Westlaw through Ch. 12 of 2016 Reg. 
Sess.). 
 153.  Robert A. Mikos, A Critical Appraisal of the Department of Justice’s New 
Approach to Medical Marijuana, 22 STAN. L. & POLY. REV. 633, 636 (2011). 
 154.  Id. at 636–37. 
 155.  Id. at 637. 
 156.  Juliet Lapidos, The Public Lightens Up about Weed, N.Y. TIMES, July 26, 2014, 
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according to the Pew Research Center.157 According to a 2013 
survey by the Pew Research Center, three out of four Americans 
believe marijuana has legitimate medical uses and that people with 
serious illnesses should have safe and legal access to it.158 What 
could be the rationale for this change in view? Looking at some of 
the reasons and rationale advanced for finding in favor of 
legalization may highlight the current trend towards acceptance of 
marijuana presently seen in the country.159 
A. Medical Marijuana is Proven to be Effective in the Treatment of a 
Variety of Debilitating Medical Conditions 
Public opinion on medical marijuana has shifted dramatically 
in the last two decades:160 twenty-three states and Washington, D.C., 
have adopted laws that allow people with certain medical 
conditions to use medical marijuana, and similar laws are being 
considered in states around the country.161 Many conservative states 
have attempted to preempt abuse of medical marijuana by passing 
laws permitting epilepsy patients to use strains of cannabis high in 
CBD.162 Again, as stated previously, the federal government still lists 
cannabis as a Schedule I drug and therefore still does not 
acknowledge any legitimate medical use.163 However, most states 
clearly disagree, as shown by the increase in state legislation 
 
at SR10. 
 157.  Id. 
 158.  MICHAEL DIMOCK, CARROLL DOHERTY & SETH MOTEL, PEW RESEARCH CTR., 
MAJORITY NOW SUPPORTS LEGALIZING MARIJUANA 6 (2013), http://www.people         
-press.org/2013/04/04/majority-now-supports-legalizing-marijuana/. 
 159.  See infra Part V (arguing for legalization of marijuana). 
 160.  Lapidos, supra note 156, at SR10. 
 161.  Editorial Board, Repeal Prohibition, Again, N.Y. TIMES (July 27, 2014), 
http://www.nytimes.com/interactive/2014/07/27/opinion/sunday/high-time      
-marijuana-legalization.html?_r=0; Therese A. Clarke Arado & Annie Mentkowski, 
Medical Marijuana: An Overview of Select Resources, 35 N. ILL. U. L. REV. 461, 462–81 
(2015) (providing an overview of state laws concerning the legalization of medical 
marijuana). 
 162.  Editorial Board, supra note 161. The New York Times lists epilepsy, along 
with pain from AIDS and nausea from chemotherapy, as afflictions that cannabis 
has been shown to alleviate. Added to this list is glaucoma, Crohn’s disease, muscle 
spasms related to multiple sclerosis, and a host of other conditions marijuana has 
effectively treated. Id. 
 163.  Aurit, supra note 3, at 549. 
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embracing medical marijuana.164 In the last two decades, there has 
been a dramatic increase in the number of states with some form of 
medical marijuana law.165 In spite of this, marijuana is still legally 
risky to use for those millions of people who would benefit from 
use.166 Relaxing medical marijuana laws would be an aid to many 
patients but prohibition would inflict great harm to those who 
would find it helpful.167 “People who would benefit from medical 
marijuana should not have to wait—and in some cases cannot 
wait—for the right to use it legally.”168 Studies have demonstrated 
that use of medical marijuana is safe and effective for people 
suffering from a variety of debilitating medical conditions.169 For 
example, a University of California study published in February 
2007 found that “marijuana relieves neuropathic pain (pain caused 
by damage to nerves), a symptom commonly associated with 
multiple sclerosis, HIV/AIDS, diabetes, and a variety of other 
conditions for which conventional pain drugs are notoriously 
inadequate—and it did so with only minor side effects.”170 
Physicians show strong support for the use of medical 
marijuana.171 In 2005, a national survey was carried out by HCD 
Research and the Muhlenberg College Institute of Public 
Opinion.172 Of those doctors surveyed, 73 percent were in favor of 
the use of “marijuana to treat nausea, pain, and other symptoms 
associated with AIDS, cancer, and glaucoma.”173 Among those 
doctors, 56 percent said they were willing to recommend medical 
 
 164.  Id. 
 165.  Id. at 552. 
 166.  Id.  
 167.  Editorial Board, supra note 161.  
 168.  Effective Arguments for Medical Marijuana Advocates, MARIJUANA POLICY 
PROJECT (July 7, 2014) [hereinafter Effective Arguments], https://www.mpp.org 
/issues/medical-marijuana/effective-arguments-for-medical-marijuana/ (last 
visited Mar. 13, 2016). 
 169.  Id. at 2. 
 170.  Id. (citing D. Abrams et al., Cannabis in Painful HIV-Associated Sensory 
Neuropathy: A Randomized Placebo-Controlled Trial, 68 NEUROLOGY 515 (2007)); R.J. 
Ellis et al., Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, 
Crossover Clinical Trial, 34 NEUROPSYCHOPHARMACOLOGY 672 (2008); see also B. 
Wilsey et al., A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in 
Neuropathic Pain, 9 J. PAIN 506 (2008).  
 171.  Effective Arguments, supra note 168, at 4 (citing HCD RESEARCH, 
Physicians and Consumers Approve of Medical Marijuana Use (June 9, 2009)). 
 172.  Id.  
 173.  Id.  
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marijuana to their patients if authorized by state law, “even if it 
remained illegal under federal law.”174 
B. Prohibition Has Enormous Social Costs 
There is no evidence that supports that the rigorous efforts in 
enforcing marijuana laws in the United States translates to lowering 
rates of marijuana use.175 Scholars Katherine Beckett and Steve 
Herbert found in their research that the collective cost of 
marijuana prevention is great to the public and society as a whole, a 
fact they believe is not even contemplated by policy makers.176 
Looking at some statistical data may be helpful in appreciating the 
costs that may be involved. 
According to the Federal Bureau of Investigation’s database, 
“[t]here were 658,000 arrests for marijuana possession in 2012.”177 
This number dwarfs the “256,000 [arrests] for cocaine, heroin, and 
their derivatives” combined.178 These arrests take officers away from 
more urgent crimes and have serious consequences for the 
arrested.179 “The hundreds of thousands of people who are arrested 
each year but do not go to jail also suffer; their arrests stay on their 
records for years, crippling their prospects for jobs, loans, housing 
and benefits.”180 As such, “a single marijuana arrest can have dire 
consequences.”181 
The benefits of criminalization are not necessarily outweighed 
by marijuana prohibition.182 Like other government initiatives, 
 
 174.  Id.  
 175.  See KATHERINE BECKETT & STEVE HERBERT, CONSEQUENCES AND COSTS OF 
MARIJUANA PROHIBITION 27 (2009), https://aclu-wa.org/library_files 
/MarijuanaProhibition.pdf. 
 176.  Id.  
 177.  Jesse Wegman, Editorial, The Injustice of Marijuana Arrests, N.Y. TIMES (July 
28, 2014), http://www.nytimes.com/2014/07/29/opinion/high-time-the-injustice 
-of-marijuana-arrests.html?_r=0. 
 178.  Id. 
 179.  Id.; see also Owen Poindexter, 6 Powerful Reasons to Legalize Marijuana, from 
the New York Times, ALTERNET (July 31, 2014), http://www.alternet.org/drugs/6      
-powerful-reasons-new-york-times-says-end-marijuana-prohibition (citing and 
reflecting on Wegman, supra note 177); State Marijuana Laws Map, GOVERNING: 
THE STATES AND LOCALITIES (July 11, 2015), http://www.governing.com/gov-data 
/state-marijuana-laws-map-medical-recreational.html. 
 180.  Wegman, supra note 177.  
 181.  Poindexter, supra note 179.  
 182.  Id. 
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cannabis prohibition is costly.183 The real question to ask is whether 
the criminalization of marijuana use has impacted the war on 
drugs, especially when one sees that the amount spent annually in 
the United States on the war on drugs is more than fifty-one billion 
dollars.184 Additionally, 1.5 million people were arrested in 2013 in 
the United States for nonviolent drug charges.185 The “[n]umber of 
people arrested for a marijuana law violation in 2013 [was] 
693,482” and 88 percent of those arrested were only charged with 
possession.186 However, even “[a]fter three decades, criminalization 
has not affected general usage [given that] about 30 million 
Americans use marijuana every year.”187 The peripheral issue is the 
“broken windows” theory—that marijuana “users are more likely to 
be involved in other crimes, and arresting them for possession can 
nip a life of crime in the bud.”188 
The New York Times makes it clear that the data does not 
support this theory.189 It illustrates this point using “a 2012 Human 
Rights Watch report, [which] tracked 30,000 New Yorkers” who 
had a clean record at the time “they were arrested for marijuana 
possession.”190 Of those 30,000 people, 90 percent had no 
subsequent felony convictions.191 “Only 3.1[percent have since] 
been convicted of one violent felony offense.”192 The high 
associated with smoking of marijuana has never been stereotyped 
as causing violence and there is no truthful case to be made that 
smoking marijuana leads to a life of crime (other than smoking 
marijuana).193 
 
 183.  See Wegman, supra note 177. 
 184.  See Drug War Statistics, DRUG POLICY ALLIANCE (2015), http://www 
.drugpolicy.org/drug-war-statistics. 
 185.  Id. 
 186.  Id. 
 187.  Wegman, supra note 177. 
 188.  Poindexter, supra note 179 (defining and then rejecting “broken 
windows” theory). 
 189.  See Wegman, supra note 177. 
 190.  Id. 
 191.  Id. 
 192.  Few Arrested for Pot Become Violent Criminals: Police Offer No Public Safety 
Explanation for Massive Marijuana Arrests, HUMAN RIGHTS WATCH (Nov. 23, 2012), 
https://www.hrw.org/news/2012/11/23/us/new-york-few-arrested-pot-become     
-violent-criminals. 
 193.  Poindexter, supra note 179. 
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C. Prohibition is Racist 
From the beginning of the movement to criminalize the use of 
marijuana in the 1930s, the campaign was rooted in xenophobia 
and prejudice against Mexican immigrants and African Americans, 
who were associated with marijuana use at the time.194 In fact, the 
choice to use the Spanish-Mexican word “marijuana” to refer to the 
cannabis plant was commensurate with associating the plant with 
Mexicans.195 
Harry Anslinger was one of the biggest supporters of 
criminalization.196 His articulation of the reasons to make cannabis 
illegal clearly reveals his racist justification for criminalization of 
marijuana: 
There are 100,000 total marijuana smokers in the U.S., 
and most are Negroes, Hispanics, Filipinos and 
entertainers. Their Satanic music, jazz and swing result 
from marijuana usage. This marijuana causes white 
women to seek sexual relations with Negroes, entertainers 
and any others . . . . Reefer makes darkies think they’re as 
good as white men.197 
Needless to say, the above racist statement speaks volumes as to 
the raison d’être for the Anslinger push for criminalization—to 
detain blacks and Mexicans. The disparity in enforcement of 
marijuana laws indicates strong racial undertones.198 According to a 
2013 ACLU report, although blacks and whites use marijuana at 
about the same rate on average, “blacks are 3.7 times more likely” 
to be arrested for possession than whites, thus showing a disparity 
in enforcement which undoubtedly indicates strong racial 
undertones.199 Perhaps the reason for the disparities in arrests is 
that “[t]he war on drugs aims its firepower overwhelmingly at 
 
 194.  See Alfonso Serrano, Weed All about It: The Origins of the Word ‘Marijuana’, 
ALJAZEERA AMERICA (Dec. 14, 2013), http://america.aljazeera.com/articles/2013 
/12/14/weed-all-about-ittheoriginsofthewordamarijuanaaintheus.html. 
 195.  Id. 
 196.  He became the first commissioner of the Federal Bureau of Narcotics—
the DEA’s predecessor. See Staples, supra note 67. 
 197.  Nick Wing, Marijuana Prohibition Was Racist from the Start. Not Much Has 
Changed, THE HUFFINGTON POST: HUFFPOST POLITICS (Jan. 14, 2014, 2:02 PM), 
http://www.huffingtonpost.com/2014/01/14/marijuana-prohibition-racist_n 
_4590190.html. 
 198.  Id. 
 199.  Wegman, supra note 177. 
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African Americans on the street, while white users smoke safely 
behind closed doors.”200 
D. Legalization Will Not Lead to Increased Use 
Legalizing and regulating marijuana will be more beneficial to 
society than prohibition, considering the level of oversight available 
for administration over legal markets and the lack of enforcement 
capacity over illegal markets. Data from the last twenty years reveal 
that the rate of underage drinking has been impacted by drinking 
laws and market campaigns, resulting in about a 10% drop in 
underage alcohol use since 2011.201 Similarly, “cigarette use among 
high school students is at its lowest point,” which apparently 
corresponds to an increase in “tobacco taxes and [the] growing 
municipal smoking limits.”202 In fact, there does not appear to be a 
link between the passage of medical marijuana laws and increased 
use in teens, rather in many cases it tends to be associated with 
decreased teen use instead.203 In an interview examining a 2012 
study conducted by researchers at universities in Colorado, 
Montana, and Oregon, that was co-authored by Daniel I. Rees, 
Professor of Economics at the University of Colorado, Professor 
Rees explained the study demonstrated “no statistical evidence that 
legalization increases the probability of [teen] use,” and also noted 
that “the data [rather] showed a negative relationship between 
legalization and [teen] marijuana use.”204 Student surveys from 
states with medical marijuana laws have predictably reported 
decreases in teen marijuana use since the passage of those laws.205 
An annual study, carried out by the U.S. Centers for Disease 
Control and Prevention and reported in 2012, found that 
 
 200.  Id. 
 201.  Philip M. Boffey, What Science Says about Marijuana, N.Y. TIMES (July 30, 
2014), http://www.nytimes.com/2014/07/31/opinion/what-science-says-about     
-marijuana.html?_r=0.  
 202.  Id. 
 203.  See KAREN O’KEEFE ET AL., MARIJUANA POLICY PROJECT, MARIJUANA USE BY 
YOUNG PEOPLE: THE IMPACT OF STATE MEDICAL MARIJUANA LAWS 2 (2011). There is 
some early data that regulation in Colorado correlates with a decrease in teen use. 
Boffey, supra note 201. 
 204.  David Kelly, Study Shows No Evidence Medical Marijuana Increases Teen Drug 
Use, U. COLO. DENVER (June 18, 2012), http://www.ucdenver.edu/about 
/newsroom/newsreleases/Pages/medical-marijuana-teenagers.aspx. 
 205.  O’KEEFE ET AL., supra note 203, at 20. 
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“marijuana use by Colorado high school students has dropped 
since the state began regulating medical marijuana in 2010.”206 A 
similar result is seen in California.207 The state-sponsored California 
Student Survey (CSS) reporting marijuana use by California teens 
revealed that marijuana use took a dramatic nosedive in 1996—the 
year California adopted its medical marijuana law—decreasing by 
almost half in some age groups.208 An independent study carried 
out in California in 1997–98 analyzing the effects of medical 
marijuana law209 concluded that “[t]here is no evidence supporting 
that the passage of Proposition 215 increased marijuana use during 
this period.”210 
E. Cannabis Is Less Harmful than Alcohol or Tobacco 
The illegal market for medical marijuana—which operates 
without standards, regulations, or price controls—poses the 
greatest hazard to public wellbeing; legalization is the inherent 
humane response to this market.211 One major argument being 
made by supporters of legalization is to compare the negative 
health effects of smoking marijuana—which is a criminal act—with 
 
 206.  See Effective Arguments, supra note 168 (citing Centers for Disease 
Control and Prevention, Youth Risk Behavior Surveillance—United States 2011, 
MORBIDITY & MORTALITY WKLY. REP. (June 8, 2012), http://www.cdc.gov/mmwr 
/pdf/ss/ss6104.pdf). 
 207.  MARIJUANA POLICY PROJECT, FACTS AND COMMON MISCONCEPTIONS 11 (Feb. 
13, 2014) [hereinafter FACTS AND COMMON MISCONCEPTIONS], http://www.legis 
.state.ak.us/basis/get_documents.asp?session=28&docid=21084; see GREGORY 
AUSTIN & RODNEY SKAGER, 11TH BIENNIAL CALIFORNIA STATEWIDE SURVEY OF 
CALIFORNIA STUDENTS GRADES 7, 9 AND 11, (WestEd ed. 2008), https://www 
.wested.org/online_pubs/hhdp/css_11th_highlights.pdf (explaining different 
marijuana smoking trends in grades 7, 9, and 11). 
 208.  GREGORY AUSTIN & RODNEY SKAGER, EXECUTIVE SURVEY: 7TH BIENNIAL 
STATEWIDE SURVEY OF DRUG AND ALCOHOL USE AMONG CALIFORNIA STUDENTS IN 
GRADES 7, 9, AND 11 (Cal. Att’y Gen.’s Office 2001), http://digitalcommons.law 
.ggu.edu/cgi/viewcontent.cgi?article=1097&context=caldocs_agencies (internal 
citation omitted). 
 209.  FACTS AND COMMON MISCONCEPTIONS, supra note 207, at 11. 
 210.  AUSTIN & SKAGER, EXECUTIVE SURVEY, supra note 208. 
 211.  Poindexter, supra note 179 (“It is the illegal market, with no standards, 
regulations or price controls, that poses a menace to public health. Our current 
federal laws, which treat cannabis as equivalent to cocaine and heroin, mostly 
teach teenagers that the government is completely unrealistic on matters of drug 
policy. Legalization is the first step in a broader initiative of treating cannabis use 
as a public health issue.”). 
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the negative health effects associated with smoking tobacco—a 
legal, socially accepted act.212 In 1999, the Institute of Medicine 
reported, “[t]here is no conclusive evidence that marijuana causes 
cancer in humans, including cancers usually related to tobacco 
use.”213 This was confirmed in 2006 with the release of a study 
conducted to investigate the respiratory effects of marijuana 
smoking and cigarette smoking by the University of California at 
Los Angeles.214 The study, conducted by Dr. Donald Tashkin, found 
that marijuana smoking was not associated with an increased risk of 
developing lung cancer.215 The data suggested that “people who 
smoked more marijuana were not at any increased risk compared 
with those who smoked less marijuana or none at all.”216 A number 
of researchers have suggested that the evidence points to a 
“possible protective effect of marijuana” against lung cancer.217 
Similarly, a study conducted in 2012 found no adverse effects on 
pulmonary function in subjects who smoked a joint a day for seven 
years.218 In fact, in a recent Pew Research Center Study, the public 
reported thinking of marijuana as less harmful to both personal 
health and society as a whole than alcohol by a wide margin.219 
 
 212.  Effective Arguments, supra note 168. 
 213.  JANET E. JOY ET AL., INSTITUTE OF MEDICINE, MARIJUANA AND MEDICINE: 
ASSESSING THE SCIENCE BASE 119 (1999). The Institute of Medicine is a division of 
the National Academies of Sciences, Engineering, and Medicine which was 
founded in 1863 by President Abraham Lincoln to “investigate, examine, 
experiment, and report upon any subject of science.” Who We Are, NAT’L ACADS. 
SCI., ENG’G, & MED. (July 24, 2015), http://national-academies.org/about 
/whoweare/index.html; About the IOM, NAT’L ACADS. SCI., ENG’G, & MED. (July 24, 
2015), http://iom.nationalacademies.org/About-IOM.aspx. 
 214.  American Thoracic Society, Study Finds No Link between Marijuana Use and 
Lung Cancer, SCIENCE DAILY (May 26, 2006), http://www.sciencedaily.com 
/releases/2006/05/060526083353.htm. 
 215.  Id. The study was conducted by Dr. Donald Tashkin at the University of 
California at Los Angeles. Id. 
 216.  Id. 
 217.  Effective Arguments, supra note 168 (quoting MiaMia Hashibe et al., 
Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a 
Population-Based Case-Control Study, 15 CANCER EPIDEMIOLOGY, BIOMARKERS AND 
PREVENTION 1829–34 (2006)). 
 218.  Boffey, supra note 201; Mark J. Pletcher et al., Association between 
Marijuana Exposure and Pulmonary Function over 20 Years, J. AM. MED. ASS’N, (Jan. 11, 
2012), http://jama.jamanetwork.com/article.aspx?articleid=1104848. 
 219.  U.S. Politics & Policy, America’s New Drug Policy Landscape, PEW RESEARCH 
CTR. (Apr. 2, 2014), http://www.people-press.org/2014/04/02/americas-new        
-drug-policy-landscape/. 
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Further, seventy-six percent of the American public “think that 
people convicted of possessing small amounts of marijuana should 
not have to serve time in jail.”220 
VI. STATE V. FEDERAL PERSPECTIVES: PAST AND PRESENT 
Historically, the public policy of the federal government as it 
pertains to marijuana has undergone tremendous tidal shifts.221 As 
previously discussed, marijuana was initially listed as a medical drug 
in the U.S. Pharmacopoeia in the early 1850s and continued to be 
legally permitted after the passage of the Marijuana Tax Act in 
1937.222 However, a few years later, marijuana was removed from 
the U.S. Pharmacopoeia and was “stripped of its designation as 
acceptable for medical use.”223 Then, in 1968, the federal 
government launched a program to grow marijuana and make it 
available to researchers.224 Yet, in 1970, Congress enacted the CSA, 
officially classifying marijuana as a Schedule I controlled 
substance—partly because it was lacking an accepted medical use in 
the United States.225 In spite of this designation of marijuana, the 
government instituted an investigational new drug (IND) program 
allowing “compassionate use” of marijuana to research its 
treatment of medical conditions.226 
Taking a look at the case of a patient named Robert Randall, 
infra, for example, will demonstrate that the relief marijuana may 
provide some patients is real and how the extenuating 
circumstances make it even desperate.227 It also shows when and 
what may be considered under “compassionate use,” and how 
 
 220.  Id. 
 221.  See infra Part VI—State v. Federal Perspectives: Past and Present.  
 222.  David F. Musto, The History of the Marihuana Tax Act of 1937, SCHAFFER 
LIBRARY DRUG POLICY (Feb. 1972), http://www.druglibrary.org/schaffer/hemp 
/history/mustomj1.html. 
 223.  Moira Gibbons, The Cannabis Conundrum: Medication v. Regulation, 24 
HEALTH LAWYER 1, 5 (Dec. 2011) (quoting Kathleen Ferraiolo, From Killer Weed to 
Popular Medicine: The Evolution of American Drug Control Policy 1937–2000, 19 J. POL. 
HIST. 147, 154–55 (2007)). The Marijuana Tax Act imposed taxes on the 
importation, manufacture, prescribing, dispensing, administering and giving away 
of marijuana, established registration requirements, and set forth penalties if tax 
payments were not made. Id. 
 224.  Nat’l Advisory Council on Drug Abuse, supra note 110. 
 225.  Aurit, supra note 3, at 549. 
 226.  Nat’l Advisory Council on Drug Abuse, supra note 110. 
 227.  Aurit, supra note 3, at 560. 
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patients in similar situations would benefit from legal access to 
marijuana.228 
“In 1976, the Department of Health, Education, and Welfare 
(HEW) approved a petition filed on behalf of Robert Randall, a 
twenty-eight-year-old glaucoma patient.”229 Randall requested a 
supply of government marijuana, grown for research, to aid in his 
treatment of glaucoma.230 He demonstrated that he had been 
subjected to an exhaustive regime of examinations and trials of 
every available medication, but they had failed to successfully treat 
his glaucoma.231 In 1976, a federal judge ruled that his use of 
marijuana was a “‘medical necessity.’”232 However, in 1978, federal 
agencies sought to silence Randall as an outspoken proponent of 
legalization by disrupting his legal access to marijuana.233 Randall 
sued the FDA, the DEA, the NIDA, the DOJ, and HEW to resume 
his legal use.234 Consequently, NIDA “resumed supplying Randall 
with medical marijuana in settlement of a lawsuit that he had filed 
in 1978.”235 Following Randall’s success, “a modest number of 
additional individuals and their physicians [came forward] to 
petition the federal government for access to medical marijuana 
through the IND process.”236 However, in 1992 the Department of 
Health and Human Services (HHS) took over after HEW ended 
the marijuana IND program, and as a result did not admit new 
enrollees.237 
In the 1980s, the Reagan Administration’s drug control policy 
was “Just Say No.”238 It was firm, it was resolute, and it went 
unchallenged by anything other than fringe protest.239 Not until the 
Clinton Administration did the DEA start to confront a 
 
 228.  Id.  
 229.  Gibbons, supra note 223, at 5. 
 230.  Id. 
 231.  Id. 
 232.  United States v. Randall, 104 Daily Wash. L. Rptr. 2251 (D.C. Super. Ct. 
1976). 
 233.  Gibbons, supra note 223, at 5 
 234.  Randall, 104 Daily Wash L. Rptr. 2251. 
 235.  Gibbons, supra note 223, at 5. 
 236.  Id.  
 237.  Id. (“However, NIDA continues to provide government-grown marijuana 
to a handful of remaining patients.”). 
 238.  See Gibbons, supra note 223, at 5. 
 239.  Id. 
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groundswell of medical marijuana advocacy at the state level.240 Just 
a year before Clinton took office, in 1992, “the DEA denied a 
petition to reschedule marijuana from Schedule I to Schedule II, 
citing lack of adequate and well-controlled studies proving the 
drug’s efficacy and no expert recognition of its medicinal value.”241 
By 1994, the DEA put in place a policy that would “assist state and 
local law enforcement agencies [fight] to oppose marijuana 
legalization.”242 This policy assistance did not seem to be effective 
given that five states still implemented medical marijuana programs 
in the early 2000s during the George W. Bush Administration.243 
After the terrorist attacks of September 11, 2001, the Bush 
Administration reallocated resources, including some of the DEA’s 
manpower and budget, to combat terrorism.244 The administration 
was still vehemently opposed to the legalization of medical 
marijuana.245 The DOJ campaigned forcefully against medical 
marijuana programs under the Clinton and George W. Bush 
Administrations.246 As a corollary of this continued policy, the DEA 
“raided hundreds of medical marijuana dispensaries and 
threatened to derail the careers of physicians who recommended 
marijuana use to their patients.”247 
The Supremacy Clause of the U.S. Constitution, as the core 
foundation of the federal government’s power over individual 
states, makes it clear that individual states cannot interfere with the 
operation of the laws enacted by the federal government.248 
Therefore, the individual states should not be able to circumvent 
the federal laws banning the use of marijuana for medical 
 
 240.  Id.  
 241.  Id.  
 242.  Id.  
 243.  Id. See generally Historical Timeline, supra note 33. 
 244.  Gibbons, supra note 223, at 5; see also Dep’t of Justice, Fact Sheet: Justice 
Department Counter-Terrorism Efforts Since 9/11 (2008), http://www.justice.gov 
/archive/opa/pr/2008/September/08-nsd-807.html. 
 245.  Gibbons, supra note 223, at 5. 
 246.  Id.  
 247.  Mikos, supra note 153, at 633. 
 248.  U.S. CONST. art. VI, § 2. The Supremacy Clause reads:  
The Constitution, and the Laws of the United States which shall be 
made in Pursuance thereof; and all Treaties made, or which shall be 
made, under the Authority of the United States, shall be supreme Law 
of the Land; and the judges in every State shall be bound thereby, any 
Thing in the Constitution or Laws of any State to the Contrary 
notwithstanding. Id. 
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purposes, which have been enacted by the federal government.249 
Consequently, the issue of preemption arises when a federal and 
state statute conflict on the same subject matter.250 Federal law 
preempts state law on the matter of regulating controlled 
substances.251 The Supremacy Clause requires that courts follow 
federal rather than state law.252 While the federal government can 
enforce its drug policies, it remains uncertain whether federal 
enforcement agencies will investigate and prosecute individuals 
acting against such policies under state law or will instead conserve 
resources for more urgent matters.253 
In October of 2009, the Obama Administration directed the 
then U.S. Deputy Attorney General, David W. Ogden, to send a 
memo (Ogden Memo) to federal prosecutors encouraging them 
not to prosecute people who distribute marijuana for medical 
purposes in accordance with state law.254 The Ogden Memo was 
intended to give clarification and guidance to federal prosecutors 
in states that had enacted legislation allowing the medical use of 
marijuana.255 The Ogden Memo did not decriminalize marijuana or 
provide a legal defense to any violations of federal law, the memo 
merely acknowledged the use of economic triage in prosecutorial 
matters: 
[A]s a general matter, pursuit of [traffickers of illegal 
drugs] should not focus federal resources in your States 
on individuals whose actions are in clear and 
unambiguous compliance with existing state laws 
providing for the medical use of marijuana. For example, 
prosecution of individuals with cancer or other serious 
illnesses who use marijuana as part of a recommended 
treatment regimen consistent with applicable state law, or 
those caregivers in clear and unambiguous compliance 
with existing state law who provide such individuals with 
 
 249.  See, e.g., Kathryn L. Blaine, Supreme Court “Just Says No” to Medical 
Marijuana: A Look at United States v. Oakland Cannabis Buyers’ Cooperative, 39 
HOUS. L. REV. 1195, 1217–18 (2002). 
 250.  Id.; see Cooper v. Aaron, 358 U.S. 1, 18 (1958). 
 251.  Blaine, supra note 249, at 1219. 
 252.  Gonzales v. Raich, 545 U.S. 1, 29 (2005).  
 253.  Claire Frezza, Medical Marijuana: A Drug without a Medical Model, 101 GEO. 
L.J. 1117, 1127 (2013). 
 254.  Ogden Memo, supra note 136. 
 255.  Id.  
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marijuana, is unlikely to be an efficient use of limited 
federal resources.256 
Importantly, while the Ogden Memo acknowledged the broad 
discretion enjoyed by federal prosecutors, it urged that limited 
federal agency resources not be spent investigating and prosecuting 
those complying with existing state laws.257 
It was first thought that the Ogden Memo represented a 
groundbreaking shift in federal drug policy—especially given it was 
the federal government’s first time explicitly renouncing 
enforcement against persons who used the drug without violating 
state law.258 However, the interpretations of federal policy are as 
varied as the commentary.259 One commentator stated that while 
the Memo “reflects the [Obama Administration’s] belief that 
federal law enforcement resources could be better spent enforcing 
other federal criminal laws” aimed at preventing horrors like 
terrorism, “it does not constitute an endorsement of medical 
marijuana.”260 The above policy has been drafted “to empower state 
governments to regulate medical marijuana” based on local 
choices.261 The memo therefore implicitly recognizes that some 
states do not share the federal government’s hostility towards 
marijuana.262 
Thus, in 2011, states and cities were continuing to move in the 
direction not only of decriminalization, but also towards the 
establishment of “‘clear and unambiguous’ distribution 
programs.”263 As a result, Oakland’s city attorney asked the DOJ for 
guidance concerning the implementation of a 2010 ordinance 
calling for the city to accept fees from and issue permits to large-
scale commercial marijuana producers.264 U.S. Attorney Melinda 
Haag retorted that growing, distributing, and possessing marijuana 
violates federal law under the CSA unless it is part of a federally 
 
 256.  Id. 
 257.  Id. 
 258.  Historical Timeline, supra note 33. 
 259.  See, e.g., Mikos, supra note 153, at 639–40. 
 260.  Id.  
 261.  Id. at 640. 
 262.  See Ogden Memo, supra note 136. 
 263.  Karen O’Keefe, State Medical Marijuana Implementation and Federal Policy, 
16. J. HEALTH CARE L. & POL. 39, 53 (2013) [hereinafter State Implementation] 
(citing OAKLAND, CAL., ORDINANCE 13033 (July 27, 2010)). 
 264.  Id.  
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approved research project.265 She clarified that “while the 
department does not focus its limited resources on seriously ill 
individuals who use marijuana . . . in compliance with state 
law . . . we will enforce the CSA vigorously against individuals and 
organizations that participate in unlawful manufacture and 
distribution activity involving marijuana, even where such activities 
are permitted under state law.”266 Similarly, in a response to 
Washington state’s governor Christine Gregoire’s request for 
clarification from the DOJ on legislation to regulate dispensaries in 
her state, the DOJ responded by reiterating the Oakland city 
response and adding that “state employees who conduct[] activities 
mandated by the Washington legislative proposals would not be 
immune from liability under the CSA.”267 The year 2011 is generally 
marked by similar letters from U.S. Attorneys to inquiring elected 
officials in states such as Arizona, Colorado, Hawaii, Maine, 
Montana, Rhode Island, and Vermont, giving virtually the same 
response: “the CSA may be vigorously enforced against those 
individuals and entities who operate large marijuana production 
facilities.”268 In the spring of 2011, the DEA raided marijuana 
dispensaries in many states, and in particular in Washington, 
seizing marijuana.269 
The DOJ then issued the Cole Memorandum to DOJ attorneys 
in June 2011 (2011 Cole Memo) stating that commercial cultivation 
or distribution of marijuana is subject to federal criminal 
 
 265.  Id.  
 266.  Id. (quoting Letter from Melinda Haag, U.S. Att’y for the N. Dist. of Cal., 
to John Russo, Oakland City Att’y (Feb. 1, 2011) (on file with the Journal of 
Health Care Law & Policy)); see also Michael Roberts, Medical Marijuana: Does 
Melinda Haag’s Memo Foreshadow Federal MMJ Raids in Colorado?, WESTWORD (Mar. 
25, 2011), http://www.westword.com/news/medical-marijuana-does-melinda         
-haags-memo-foreshadow-federal-mmj-raids-in-colorado-5838853. 
 267.  State Implementation, supra note 263, at 54. Governor Christine Gregoire 
vetoed the portion of the law that would have regulated dispensing to avoid 
putting State employees in legal danger. Id. Fearing federal policy, the state missed 
an opportunity to regulate its dispensaries, a striking problem when noted that 
Seattle alone has over 100 dispensaries. Id. See Jonathan Martin, Seattle Pot 
Dispensaries Finding Business Climate No Longer Sunny, SEATTLE TIMES (Sept. 5, 2012), 
http://www.seattletimes.com/seattle-news/seattle-pot-dispensaries-finding              
-business-climate-no-longer-sunny/. 
 268.  State Implementation, supra note 263, at 55. 
 269.  Id. at 53–55; Rob Kauder, Authorities Raid Spokane Medical Marijuana 
Dispensaries, KXLY (Sept. 9, 2011, 5:11 PM), http://www.kxly.com/news 
/Authorities-Raid-Spokane-Medical-Marijuana-Dispensaries/680580. 
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prosecution even if the operation complies with state law.270 The 
2011 Cole Memo similarly recognized that it was “likely not an 
efficient use of federal resources to focus enforcement efforts on 
individuals with cancer or other serious illness who use marijuana 
as part of a recommended treatment regimen consistent with 
applicable state law, or their caregivers.”271 The 2011 Cole Memo 
appears to be more limited than the Ogden Memo, defining 
caregivers only as those caring for the seriously ill, “not commercial 
operations cultivating, selling or distributing marijuana.”272 
Thus, the 2011 Cole Memo clarified that the Ogden Memo was 
never intended to shield large-scale manufacturers of marijuana 
with “revenue projections of millions of dollars based on the 
planned cultivation of tens of thousands of cannabis plants” 
regardless of whether they apparently comply with state law.273 
Subsequently, medical marijuana proponents complained that the 
2011 Cole Memo apparently contradicted the Ogden Memo 
because while the Ogden Memo emphasized that prosecutors do 
not need to prosecute individuals and caregivers who were in clear-
cut compliance with state medical marijuana laws, the 2011 Cole 
Memo apparently encouraged prosecution.274 
In June 2011, the DEA, working closely with NIDA, rejected a 
petition to reclassify marijuana from Schedule I to either Schedule 
III, IV, or V.275 The FDA concluded after its medical evaluation of 
marijuana that the drug met three of the eight factors to 
specifically categorize it in Schedule I.276 
 
 270.  Letter from James M. Cole, Deputy Att’y Gen., to U.S. Attorneys (June 
19, 2011), Guidance Regarding the Ogden Memo in Jurisdictions Seeking to Authorize 
Marijuana for Medical Use, U.S. DEP’T OF JUSTICE: OFFICE OF THE DEPUTY ATT’Y GEN. 
(June 29, 2011) [hereinafter 2011 Cole Memo], https://www.justice 
.gov/sites/default/files/oip/legacy/2014/07/23/dag-guidance-2011-for-medical-
marijuana-use.pdf. 
 271.  Id. 
 272.  Id.; State Implementation, supra note 263, at 55. 
 273.  2011 Cole Memo, supra note 270, at 2.  
 274.  Gibbons, supra note 223, at 5. 
 275.  Denial of Petition to Initiate Proceedings to Reschedule Marijuana, 76 
Fed. Reg. 40552–01 (July 8, 2011). 
 276.  Id. The FDA cited marijuana’s high substantive abuse potential, lack of 
any currently accepted medical use in treatment, and lack of accepted safety 
criteria for use under medical supervision. The eight factors used by the FDA in 
evaluating drugs is set forth in 21 U.S.C. § 811(c) (2012): 
(1) [Its] actual or relative potential for abuse; 
(2) Scientific evidence of pharmacological effect, if known; 
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On August 29, 2013, the DOJ announced an update to the 
marijuana enforcement policy in a memo from Deputy Attorney 
General James M. Cole (2013 Cole Memo).277 In a press release 
announcing their guidance, the DOJ stated that while marijuana 
remains illegal federally, the DOJ expects states like Colorado and 
Washington to create “strong, state-based enforcement 
efforts . . . [in return] deferring [the] right to challenge their 
legalization laws at this time.”278 It warned that the department 
reserved the right to challenge the states at any time they feel it is 
necessary.279 The pendulum has swung from blanket federal 
enforcement and outright resistance to the development of local 
regulation towards a greater autonomy in state self-governance, 
allowing states to develop systems to monitor and enforce their own 
tailored marijuana laws.280 However, the DOJ has made it 
consistently clear that marijuana remains an illegal drug under the 
CSA and that federal prosecutors will not hesitate to act if the states 
are unable to moderate the industry appropriately.281 
VII. STATE V. FEDERAL POLICIES: SOME CASE LAW SHAPING THE 
 
(3) The state of current scientific knowledge regarding the drug or 
other substance; 
(4) Its history and current pattern of abuse; 
(5) The scope, duration and significance of abuse; 
(6) What, if any, risk there is to public health; 
(7) Its psychotic or physiological dependence liability; and 
(8) Whether the substance is an immediate precursor of a substance 
that is already controlled under [the federal Controlled Substances 
Act]. 
 277.  Letter from James M. Cole, Deputy Att’y Gen., to U.S. Attorneys, 
Guidance Regarding Marijuana Enforcement, U.S. DEP’T OF JUSTICE: OFFICE OF THE 
DEPUTY ATT’Y GEN. (Aug. 29, 2011), [hereinafter 2013 Cole Memo], 
http://www.justice.gov /iso/opa/resources /3052013829132756857467.pdf.  
 278.  Press Release, Dep’t of Justice, Justice Dep’t Announces Update to 
Marijuana Enforcement Policy (Aug. 29, 2013), https://www.justice.gov/opa/pr 
/justice-department-announces-update-marijuana-enforcement-policy. 
 279.  2013 Cole Memo, supra note 277. 
 280.  See Historical Timeline, supra note 33.  
 281.  Press Release, Dep’t of Justice, supra note 278 (“To this end, the 
Department identifies eight (8) enforcement areas that federal prosecutors should 
prioritize. These are the same enforcement priorities that have traditionally driven 
the Department’s efforts in this area. Outside of these enforcement priorities, 
however, the federal government has traditionally relied on state and local 
authorizes to address marijuana activity through enforcement of their own 
narcotics laws. This guidance continues that policy.”). 
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DEBATE 
A study of the interplay between federal statutes, state statutes, 
administrative agency guidance, and enforcement would not be 
complete without case law. Case law illustrates the actual limits and 
confines of power and, as such, has massive effects on practical 
enforcement and legislative efforts. 
A. Gonzales v. Raich 
As stated above in regard to Gonzales v. Raich, California passed 
the Compassionate Use Act in 1996, which allowed for the use of 
medical marijuana.282 The defendants were properly using 
marijuana under the Compassionate Use Act and both were 
growing marijuana plants at home for their own use.283 Federal 
DEA agents seized and destroyed their marijuana plants.284 
Defendants were compliant with state laws when arrested, but guilty 
under federal DEA laws at the time.285 Defendants sued the 
Attorney General, arguing that Congress had exceeded their 
interstate commerce clause authority in legislating the behavior of 
a local citizen, consuming a locally grown herb in his own home.286 
The Supreme Court held that the Commerce Clause authorizes 
Congress to prohibit the local cultivation and use of marijuana 
even if it is in compliance with California law.287 Thus, Gonzales v. 
Raich simply stands for the fact that Congress has the authority, 
under the Commerce Clause, to prohibit marijuana use at the 
federal level.288 
B. United States v. Oakland Cannabis Buyers Cooperative 
California Proposition 215 was a voter initiative approved in 
1995 which declared that “seriously ill Californians have the right 
to obtain and use marijuana for medical purposes.”289 Under the 
law, a patient or a patient’s caregiver, upon the recommendation 
 
 282.  545 U.S. 1, 5 (2005). 
 283.  Id. at 6–7. 
 284.  Id. at 7. 
 285.  Id. at 7–9. 
 286.  Id. at 7–8. 
 287.  Id. at 32–33. 
 288.  Id. at 5. 
 289.  Compassionate Use Act of 1996, CAL. HEALTH & SAFETY CODE § 11362.5 
(West 1996). 
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or approval of a physician, may possess or cultivate marijuana for 
medical purposes and will not be punished under California law.290 
In anticipating the protection of the Compassionate Use Act, 
several medical marijuana dispensaries and cooperatives planned 
on distributing marijuana to qualified patients.291 
The federal government disagreed with the constitutionality of 
Proposition 215 and, in early 1998, filed separate lawsuits against 
six marijuana cooperatives, stating that these six cooperatives were 
functioning in violation of federal law.292 The DOJ felt that these 
cooperatives “violated the [CSA’s] prohibitions on distributing, 
manufacturing, and possessing with the intent to distribute or 
manufacture a controlled substance.”293 The government also filed 
motions for preliminary injunction, permanent injunction, and 
summary judgment in each case.294 The U.S. District Court for the 
Northern District of California held that in light of the Supremacy 
Clause of the U.S. Constitution, the cooperatives’ conduct likely 
violated federal law.295 Consequently, the district court granted 
preliminary injunction, ordering that the six cooperatives refrain 
from violating the CSA by discontinuing to engage in illegal 
distribution of marijuana.296 
One of the dispensaries, Oakland Cooperative, did not comply 
with the injunction, so the district court held Oakland Cooperative 
in contempt and modified the preliminary injunction to give 
authority to the U.S. Marshall to seize Oakland Cooperative’s 
offices.297 Although its offices were padlocked, Oakland 
Cooperative requested that the court modify the injunction to 
allow marijuana distribution to patients with a medical need. The 
district court rejected the request.298 Oakland Cooperative 
eventually changed its mind and complied with the injunction, 
resulting in the court vacating the modification in relation to 
 
 290.  Id. 
 291.  Blaine, supra note 249, at 1199. 
 292.  Id. at 1200.  
 293.  United States v. Oakland Cannabis, 532 U.S. 483, 487 (2010). 
 294.  United States v. Cannabis Cultivator’s Club, 5 F. Supp. 2d 1086, 1093 
(N.D. Cal. 1998). Six individual lawsuits were reassigned as related cases to the 
U.S. District Court for Northern District of California. Id. 
 295.  Id. at 1105. 
 296.  United States v. Cannabis Cultivator’s Club, No. C 98–0085 CRB, 1999 
WL 111893, at *1 (N.D. Cal. Feb. 25, 1999). 
 297.  Oakland Cannabis, 532 U.S. at 487. 
 298.  Id. at 488. 
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seizing the Oakland Cooperative premises.299 Oakland Cooperative 
eventually appealed three of the district court’s orders.300 The 
Ninth Circuit, after reviewing the district court orders, opined that 
it did not have jurisdiction in two of the orders, but it did review 
the third order of an appeal from the motion to modify.301 The 
Ninth Circuit accepted Oakland Cooperative’s argument in favor of 
a necessity defense. The court therefore reversed the order denying 
the modification and remanded the issue, instructing the district 
court to reconsider Oakland Cooperative’s “request for a 
modification that would exempt from the injunction distribution to 
seriously ill individuals who need cannabis for medical purposes.”302 
On remand, the district court modified the injunction against 
the six cooperatives to allow seriously ill individuals access to 
marijuana if they are able to establish a medical necessity for 
marijuana.303 As a result, the government appealed the district 
court’s modification order.304 The U.S. Supreme Court reversed the 
Ninth Circuit and held that “there is no medical necessity 
exception [or defense] to the Controlled Substances Act’s 
prohibitions on manufacturing and distributing marijuana.”305 In 
other words, the Oakland Cannabis Cooperative claimed there was 
an implied common-law medical necessity exception contained in 
the CSA that the Ninth Circuit was willing to recognize.306 The 
 
 299.  See United States v. Oakland Cannabis Buyers’ Coop., 190 F.3d 1109, 
1113 (9th Cir. 1999), rev’d, 532 U.S. 483 (2001). 
 300.  Id. at 1111 (The three orders included: “(a) an order denying OCBC’s 
motion to dismiss the complaint on the ground that an Oakland City ordinance 
makes it immune from liability under 21 U.S.C § 855(d); (b) an order 
subsequently purged and vacated that found OCBC in contempt of the injunction; 
and (c) an order denying OCBC’s motion to modify the injunction to permit 
cannabis distribution to persons having a doctor’s certificate [stating] that 
marijuana is a medical necessity for them.”). 
 301.  Oakland Cannabis Buyers’ Coop., 190 F.3d at 1111. 
 302.  Id. 
 303.  United States v. Oakland Cannabis Buyers’ Coop., No. C 98–0088 CRB, 
2000 WL 1517166, at *2 (N.D. Cal. July 17, 2000); see also Blaine, supra note 249, at 
1202 (stating “that the Government failed to offer any evidence to rebut Oakland 
Cooperative’s argument that cannabis is medically necessary for seriously ill 
individuals.”). 
 304.  See Petition for Writ of Certiorari, Oakland Cannabis Buyers’ Coop., 190 
F.3d 1109 (No. 00–151). 
 305.  United States v. Oakland Cannabis Buyers’ Coop., 532 U.S. 483, 483 
(2001). 
 306.  See Oakland Cannabis Buyers’ Coop., 2000 WL 1517166, at *1. 
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Supreme Court clarified that the only exception contained in the 
CSA for Schedule I drugs like marijuana was that for government-
approved research projects.307 The mere fact that marijuana is a 
Schedule I drug means that Congress does not acknowledge any 
medical use for marijuana.308 
This case stands for the proposition that the CSA outlaws all 
uses of medical marijuana, that there is no federal common law 
necessity defense to the CSA, and therefore marijuana is still 
banned federally.309 
C. Pearson v. McCaffrey 
Pearson v. McCaffrey made it clear that the U.S. District Court 
for the District of Columbia would not create protections for 
physicians on First, Ninth, or Tenth Amendment grounds.310 A 
group of physicians practicing medicine in states with medical 
marijuana provisions challenged the constitutionality of the CSA.311 
The physicians wanted to be sheltered from federal laws and 
continue to recommend and prescribe marijuana.312 Upon review, 
the Pearson court refused to grant a preliminary injunction against 
the government, asserting that “even if marijuana were a panacea 
for all diseases, the [c]ourt does not have the authority to grant 
[p]laintiffs’ request.”313 The court encouraged the plaintiffs to 
submit their case to the appropriate forum—the DEA—and ask it 
to reconsider rescheduling marijuana to a different class.314 
D. Emerald Steel Fabricators, Inc. v. Bureau of Labor & Industries 
In Emerald Steel Fabricators, Inc. v. Bureau of Labor & Industries, 
the Oregon Supreme Court held that an employer did not have to 
make accommodations for an employee’s medical marijuana use.315 
In articulating this holding, the court stated, “[t]o the extent that 
 
 307.  Oakland Cannabis Buyers’ Coop., 532 U.S. at 483. 
 308.  Id. at 484. 
 309.  See id. at 490. 
 310.  139 F. Supp. 2d 113, 113 (D.D.C. 2001). 
 311.  Id. at 115–17. 
 312.  Id. at 117. 
 313.  Id. at 125. 
 314.  See id. 
 315.  Emerald Steel Fabricators, Inc. v. Bureau of Labor & Indus., 230 P.3d 
518, 520 (Or. 2010). 
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[the Oregon medical marijuana statute] affirmatively authorizes 
the use of medical marijuana, federal law preempts that subsection 
[of state law], leaving it ‘without effect.’”316 Furthermore, the 
Oregon Supreme Court relied on its decision in Michigan Canners 
& Freezers Association v. Agricultural Marketing and Bargaining Board, 
and consequently held that the Oregon medical marijuana statute 
was preempted based on obstacle preemption by the CSA.317 In 
Michigan Canners, the U.S. Supreme Court held that “federal law 
prohibited food producers’ associations from interfering with an 
individual food producer’s decision whether to bring that 
individual’s products to the market” or to utilize cooperative 
associations.318 Although Michigan Canners followed federal law on 
the issue for the most part, the Court permitted associations 
representing food producers to apply to a state board for authority 
to be “the exclusive bargaining agent for all producers” of a specific 
product: 
Under Michigan’s system, if an association’s membership 
constitutes more than 50% of the producers of a 
particular commodity, and its members’ production 
accounts for more than 50% of the commodity’s total 
production, the association may apply to the state 
Agricultural Marketing and Bargaining Board for 
accreditation as the exclusive bargaining agent for all 
producers of that particular commodity.319 
Although the U.S. Supreme Court held that the state law did 
not directly contradict the federal law, the fact remains that the 
state law authorized an association to ignore federal prohibitions, 
which created enough of an obstacle to the federal law’s purpose to 
make the state law void due to preemption.320 
There are situations where state and federal legislatures have 
differing opinions on whether medical marijuana use should be 
prohibited.321 The states that have the most successfully 
implemented medical marijuana programs simply do not prosecute 
medical marijuana use, leaving any medical marijuana prosecution 
 
 316.  Id. at 529. 
 317.  Id. 
 318.  Id. at 528; see Michigan Canners & Freezers Ass’n v. Agric. Mktg. & 
Bargaining Bd., 467 U.S. 461, 462 (1984). 
 319.  Id. at 466. 
 320.  Id. at 478. 
 321.  See supra text accompanying note 136. 
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and regulation to the federal government.322 This leaves individuals 
who use medical marijuana under state law vulnerable to 
prosecution for violation of federal law, even though the state may 
not prosecute that individual.323 
VIII.THE COMPASSIONATE USE ACT: THE CASE FOR CALIFORNIA AS A 
STANDARD? 
Voters in California passed a state medical marijuana initiative 
in 1996.324 California was the first jurisdiction to decriminalize use 
and cultivation of marijuana under its Compassionate Use Act, 
known as Proposition 215, which “permits patients and their 
primary caregivers, with a physician’s recommendation, to possess 
and cultivate marijuana for the treatment of AIDS, cancer, 
muscular spasticity, migraines, and several other disorders . . . .”325 
The federal government responded swiftly to the passage of this 
first state marijuana law.326 In 1997, the Clinton Administration 
issued a harsh statement indicating the steps the government 
would take to kill the new medical marijuana movement through 
its former general, Barry McCaffrey.327 McCaffrey threatened to 
prosecute persons who supplied medical marijuana, revoke the 
prescription-writing authority of physicians who recommended 
marijuana to patients, and deny various federal benefits (including 
licenses) to anyone who used marijuana under the California law.328 
The federal government’s policy on marijuana purportedly 
adheres to the underlying principle enunciated in the CSA—that 
marijuana has “no currently accepted medical use” and therefore is 
rightfully classified as a Schedule I drug.329 Yet the federal 
government has been sending mixed signals to the states 
concerning the standing of medical uses for marijuana, as marked 
by the Ogden and Cole memoranda encouraging federal 
prosecutors not to prosecute those who obtain marijuana for 
 
 322.  See supra text accompanying note 136. 
 323.  See supra text accompanying note 136. 
 324.  CAL. HEALTH & SAFETY CODE § 11362.5. 
 325.  Historical Timeline, supra note 33. 
 326.  Notice, Administration Response to Arizona Proposition 200 and 
California Proposition 215, 62 Fed. Reg. 6164–01 (Feb. 11, 1997); Mikos, supra 
note 153, at 637. 
 327.  62 Fed. Reg. 6164–01; see supra text accompanying note 240–43.  
 328.  62 Fed. Reg. 6164–01. 
 329.  See supra Part II (discussing history of medical marijuana).  
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medical purposes.330 Yet at the same time, the fight against medical 
marijuana persisted during George W. Bush’s Administration, 
which conducted “nearly two hundred raids on [medical] 
dispensaries in California,” and even warned landlords who did not 
promptly evict marijuana-dispensing tenants that it would seize 
their property.331 
The California Compassionate Use Act established 
requirements for physicians desiring to recommend marijuana to 
patients, as well as the minimum qualification process to be used by 
doctors and those looking to obtain marijuana for medical 
purposes.332 The program requires that an attending physician 
licensed in California, upon examining a patient, determine 
whether the patient has a serious medical condition requiring the 
use of marijuana for treatment.333 The question is what is meant by 
“serious medical use?” The definition is broad, and includes 
conditions such as “arthritis, migraines, cancer, multiple sclerosis, 
seizures, severe nausea, and any other chronic or persistent 
condition” that would inhibit a major life activity or condition, and 
which, if not treated, may cause grave harm to a patient’s safety, or 
even to his or her physical or mental health.334 This is somewhat 
different from what prevails in New Mexico, where the patient must 
be unable to get adequate relief therapy before the physician can 
 
 330.  See supra Part VI (discussing the tension between the federal government 
and the state governments regarding legalization).  
 331.  Aurit, supra note 3, at 554. 
 332.  Compassionate Use Act of 1996, CAL. HEALTH & SAFETY CODE § 11362.5; 
Gibbons, supra note 223, at 5. 
 333.  Gibbons, supra note 223, at 7. 
 334.  Id. Under the California Medical Marijuana Program, physician 
marijuana recommendations must be documented in the patient’s medical 
record, which is then used by the patient to obtain an identification card through 
the health department in the county where the patient resides. After the 
submission of an application and payment of the requisite fees as required by the 
state and county, the health department proceeds to review the application for 
approval or rejection. In so doing, the department obtains a patent’s photo, 
verifies the validity of the attending physician’s credentials, i.e., that he holds a 
California physician license in good standing. It also contacts the physician to 
ensure that the patient-provided medical records recommending marijuana are 
authentic and appropriate. Patients with an ID card can purchase or grow 
marijuana for medical purposes. See Medical Marijuana Program Frequently Asked 
Questions, CAL. DEP. OF PUB. HEALTH, http://www.cdph.ca.gov/programs/MMP 
/Pages/MMPFAQ.aspx (last updated Mar. 10, 2014). 
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recommend marijuana.335 On the contrary, the California Medical 
Board guidelines for physicians expressly suggest that a patient 
does not have to wait until all standard medications have been tried 
and failed before recommending marijuana.336 In fact, all that is 
expected from a California physician is to weigh the risk/benefit 
ratio of medical marijuana, and if marijuana tends to be as good as 
or better than other medications, then the physician may prescribe 
it under state law.337 The guidelines do not require, nor do they 
specifically recommend that other medications be tried first before 
using marijuana.338 These guidelines may be the reason why some 
scholars have stated that “the real beneficiaries of the medical 
marijuana movement are doctors who hand out marijuana medical 
cards like candy.”339 In California, the marijuana boom was so 
lucrative that “robodoctors” set up offices equipped with a nurse 
and video conferencing capabilities, and charge each patient to 
issue a medical marijuana card after listening to the patient’s 
medical complaints over the internet.340 The marijuana card is only 
valid for six months and patients must pay an additional fee to 
renew the prescription.341 
In comparison, and perhaps also worth emulating, is New 
Mexico’s marijuana program. This program appears to be much 
more regulated, standing out probably because of the 
comprehensive way that the New Mexico State Department of 
Health (NMDOH) monitors the production and distribution of 
marijuana.342 The NMDOH would issue licenses to producers and 
distributors of medical marijuana.343 Under the Lynn and Erin 
Compassionate Use Act in New Mexico, patients receive protection 
from state prosecution if, firstly, their physician certifies that they 
have one of the listed medical conditions,344 secondly, that 
employing regular treatment is unlikely to be effective, and thirdly, 
 
 335.  See Reid, supra note 137, at 196–98. 
 336.  Compassionate Use Act of 1996, CAL. STAT. § 11362.5; see also Gibbons, 
supra note 223, at 7. 
 337.  Gibbons, supra note 223, at 7. 
 338.  Gibbons, supra note 223, at 7–8. 
 339.  Reid, supra note 137, at 195. 
 340.  Id. 
 341.  Id. at 196. 
 342.  See N.M. STAT. ANN. § 26-2B-7 (West, Westlaw through Ch. 2 of 2nd 2015 
Reg. Sess.); Reid, supra note 137, at 196. 
 343.  Reid, supra note 137, at 196–97. 
 344.  Id. at 197. 
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that the benefit of using marijuana for that patient in question 
outweighs the risk of its use.345 Upon receiving the certification, the 
patient could then apply to the state for a registry card.346 If the 
state approves, it then issues the patient a registry card.347 Likewise, 
the state seems to be liberal towards its citizens, as it gives patients 
the choice of growing up to sixteen marijuana plants for personal 
use.348 However, as with the California program, it has its 
shortcomings not intended by the legislature.349 At the New Mexico 
Medical Board’s April 2013 hearing, the board heard testimony 
that some patients were being approved for the program who did 
not meet the established criteria to legally use medical marijuana.350 
Some patients even received certification over the phone through 
Skype, and one clinic is said not to have even examined its patients 
before confirming their eligibility for the program.351 It was found 
that “[o]f the 12,977 applications submitted to the State 
Department of Health since the program began in 2007, only 25 
resulted in ‘flat-out denials.’”352 This demonstrates that it is not 
common for attending physicians to turn down patients. One 
physician approved ninety-eight percent of the patients he let into 
his marijuana program.353 These problems are being alleviated by 
the proposal of new rules by state regulators that require doctors 
and other health care providers periodically to re-diagnose the 
patient and to notify the patient’s health care providers.354 Whether 
the proposed regulations will actually curtail the abuse of the 
program by some doctors is uncertain.355 
What is certain is that even with more oversight by a patient’s 
state, marijuana distributors and marijuana producers, there is no 
 
 345.  Id. 
 346.  Id. 
 347.  Id. 
 348.  Id. 
 349.  See id. at 196–98. 
 350.  Colleen Heild, New Light Shed on New Mexico Medical Marijuana, 
ALBUQUERQUE J. (Aug. 11, 2013), http://www.abqjournal.com/245506/news/new 
-light-shed-on-nm-medical-marijuana.html. 
 351.  Id. 
 352.  Id. 
 353.  Id. 
 354.  Phaedra Haywood, Critics Blast Proposed New Rules for Pot Program, SANTA 
FE NEW MEXICAN (Aug. 3, 2013), http://www.santafenewmexican.com/news 
/health_and_science/article_79c2f192-b10c-554a-92df-695c77d16637.html. 
 355.  Id. 
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guarantee that the use of medical marijuana will be narrowly 
tailored for use by only those in dire need without some taking 
advantage of the lucrative business it tends to generate.356 Taking a 
closer look at the programs in California and New Mexico reveals 
that even with tighter control of medical marijuana, abuse of the 
programs cannot be eradicated completely.357 
IX. CONCLUSION 
The supposed non-enforcement policy of the federal 
government encourages federal prosecutors not to go out of their 
way to prosecute marijuana users who follow state medical laws in 
an effort to better utilize federal prosecutorial resources.358 This 
policy does not give carte blanche to patients, producers, and 
distributors as the federal prosecutors can, and do, exercise 
discretion, occasionally pursuing cases.359 States are increasingly 
ignoring their federal responsibilities and creating their own 
regulatory frameworks for an industry the federal government 
officially condemns.360 
The states have been moving towards recognizing and 
controlling the medical marijuana industry—and not merely 
decriminalizing it—since 2009.361 The states are individually 
evaluating the risks and benefits involved in recognizing the 
therapeutic value of marijuana—which has traditionally been a part 
of the FDA’s role in the regulations behind the safety and 
effectiveness of drugs—finding that the benefits in recognizing 
such therapeutic value in marijuana outweigh the risks.362 To most 
 
 356.  See generally Peter St. Cyr, No Easy Ride, SANTA FE REP. (July 9, 2013), 
http://www.sfreporter.com/santafe/article-7540-no-easy-ride.html. In 2013, New 
Mexico reported U.S.D. 3.3 million in total sales by licensed producers and 
distributors of marijuana. Id. 
 357.  Reid, supra note 137, at 194–99. 
 358.  Mikos, supra note 153, at 667–69. 
 359.  See Tim Dickinson, Obama’s War on Pot: In a Shocking About-Face, The 
Administration Has Launched a Government-Wide Crackdown on Medical Marijuana, 
ROLLING STONE (Feb. 16, 2012), http://www.rollingstone.com/politics/news 
/obamas-war-on-pot-20120216 (stating federal authorities under the Obama 
administration are regulating medical marijuana more strictly than past 
presidents, regularly pursuing distributors in compliance with state laws). 
 360.  See State Implementation, supra note 263, at 49–53 (providing an overview 
of state marijuana regulations). 
 361.  Id. 
 362.  Gibbons, supra note 223, at 7. 
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efficiently harmonize rhetoric, the federal government should 
align its policies to match the states’ policies by officially declining 
to use its limited resources on businesses and individuals in 
compliance with well-regulated state medical marijuana laws. Also, 
rescheduling marijuana from Schedule I to Schedule III or lower 
would “allow[] marijuana to be prescribed, recommended, 
dispensed from pharmacies, and possessed or manufactured by 
those authorized to do so under state medical marijuana laws.”363 
However, one of the major arguments against the federal 
government reclassifying marijuana from a Schedule I substance to 
Schedule III is that legalizing marijuana for medical purposes may 
act as a slippery slope, setting the country sliding towards outright 
marijuana legalization.364 Critics contend that “dispensaries, 
retailers, and growers of marijuana” are the only parties that stand 
to profit from reform.365 There needs to be a well-developed 
regulatory system to ensure patient safety and prevent against 
blatant abuse, but when traditional medications fail, providing 
access to marijuana for medical purposes is a humane approach to 
a difficult question.366 The inaction of Congress with respect to the 
CSA has forced the individual states to reexamine the goals of the 
CSA.367 Justice O’Connor aptly noted in her dissent in Gonzales v. 
Raich that “[o]ne of federalism’s chief virtues, of course, is that it 
promotes innovation by allowing for the possibility that ‘a single 
courageous State may, if its citizens choose, serve as a laboratory; 
and try novel social and economic experiments without risk to the 
rest of the country.’”368 
 
 363.  State Implementation, supra note 263, at 58. O’Keefe believed that the best, 
most comprehensive way to harmonize federal and state medical marijuana 
policies would be for Congress to pass H.R. 689, which would result in marijuana 
being scheduled as III or lower. Id. 
 364.  James Bell, Medical Marijuana—A Slippery Slope?, GEORGIA CARE PROJECT 
(Mar. 25, 2015), http://www.gacareproject.com/medical-marijuana-a-slippery        
-slope/. 
 365.  Reid, supra note 137, at 191 (“[W]ithout increased regulation or taxation 
that is possible through outright legalization, the medical marijuana option would 
merely exchange one drug-trafficking organization for another.”). 
 366.  Gibbons, supra note 223, at 9. 
 367.  See Graham Boyd et al., Marijuana Legalization: Does Congress Need to Act?, 
THIRDWAY.ORG (June, 10, 2014), http://www.thirdway.org/report/marijuana          
-legalization-does-congress-need-to-act; LISA N. SACCO & KRISTIN FINKLEA, STATE 
MARIJUANA LEGALIZATION INITIATIVES: IMPLICATIONS FOR FEDERAL LAW ENFORCEMENT 
5–7 (Dec. 4, 2014), https://www.fas.org/sgp/crs/misc/R43164.pdf. 
 368.  Gonzales v. Raich, 545 U.S. 1, 42 (O’Connor, J., dissenting) (quoting 
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While the states may be “experimenting” with legalizing 
medical marijuana, the federal government will be watching and 
adapting, but when pressed will merely reiterate that under the 
CSA, medical marijuana use is still illegal.369 The federal 
government’s fluctuating position, as seen in this article, leaves the 
states little direction when determining policies and effectively 
extends to the states the power to regulate their own marijuana 
markets.370 While California did not technically grant legal 
protections from federal law to patients, doctors, growers, or 
distributors by passing the Compassionate Use Act, in practice 
ninety-nine percent of all marijuana arrests happen at state or local 
level and not at the federal level.371 Does this mean an effective end 
to federal marijuana prohibition has already occurred? It is unlikely 
that federal marijuana prohibition will end soon, though the 
inaction of Congress and the executive departments (the DOJ, IRS, 
and Financial Crimes Enforcement Network) seems to indicate that 
the prohibition may have already ended, in effect.372 Only time will 
tell. 
 
 
New State Ice Co. v. Liebermann, 285 U.S. 262, 311 (1932) (Brandeis, J., 
dissenting)). 
 369.  See Boyd et al., supra note 367. 
 370.  Id.  
 371.  See State Implementation, supra note 263, at n.44 (citing FEDERAL BUREAU OF 
INVESTIGATION, CRIME IN THE UNITED STATES: UNIFORM CRIME REPORTS 1, 278–80 (2005), 
http://www2.fbi.gov/ucr/cius_04/documents/CIUS2004.pdf). 
 372.  See Boyd et al., supra note 367. 
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